UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Information Required in Proxy Statement
Schedule 14A Information
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant
þ
Filed by a Party other than the Registrant
o
Check the appropriate box:
|
|
|
o
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
þ
|
|
Definitive Proxy Statement
|
o
|
|
Definitive Additional Materials
|
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
IONA
TECHNOLOGIES PLC
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
þ
|
|
No fee required.
|
|
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5
|
)
|
|
Total fee paid:
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Fee paid previously with preliminary materials.
|
|
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing
by registration statement number, or the Form or Schedule and the
date of its filing.
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
Date Filed:
|
IONA
TECHNOLOGIES PLC
The IONA Building
Shelbourne Road, Ballsbridge
Dublin 4, Ireland
April 29,
2008
Dear Shareholder:
On behalf of the Board of Directors, I am pleased to invite you
to the 2008 Annual General Meeting of IONA Technologies PLC. The
meeting will be held at The Four Seasons Hotel, Ballsbridge,
Dublin 4, Ireland, on Monday, September 29, 2008, at
3:00 p.m. (local Irish time). I hope that you will be able
to attend the meeting.
The attached Notice of Annual General Meeting and Proxy
Statement set out the business due to be considered at this
meeting. Shareholders who are present at the meeting will have
the opportunity to ask questions of the Board of Directors.
It is important that your views be represented whether or not
you are able to attend the meeting. Please sign and date the
enclosed form of proxy and return it to us in the enclosed
envelope. Completion of this proxy form will not prevent you
from attending and voting at the meeting if you ultimately wish
to do so.
Yours sincerely,
Kevin Melia
Chairman of the Board
Directors:
Seán
Baker, Chris Horn (UK), Ivor Kenny, James Maikranz (US), Kevin
Melia,
Bruce Ryan (US), Francesco Violante (Italy), Peter Zotto
(US).
Registered Office:
The IONA Building, Shelbourne Road,
Ballsbridge, Dublin 4, Ireland
Registered Number:
171387
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE
ATTENTION. If you are in any doubt about the contents of this
document or what action you should take, you should consult your
stockbroker, bank manager, or other independent professional
adviser. If you have sold or transferred all your Ordinary
Shares in IONA Technologies PLC, please forward this document at
once to the stockbroker, bank or other agent through whom the
sale was affected for transmission to the purchaser.
IONA
TECHNOLOGIES PLC
NOTICE OF ANNUAL GENERAL
MEETING
To Be Held on
September 29, 2008
NOTICE is hereby given that the Annual General Meeting (the
Annual Meeting), of IONA Technologies PLC (the
Company) will be held at The Four Seasons Hotel,
Ballsbridge, Dublin 4, Ireland on Monday, September 29,
2008, at 3:00 p.m. (local Irish time) for the following
purposes:
1. To receive and consider the consolidated financial
statements of the Company for the fiscal year ended
December 31, 2007 and the Reports of the Directors and
Auditors thereon (Proposed Resolution No. 1).
2. To re-elect the following persons who retire by rotation
pursuant to Article 80(c) of the Articles of Association of
the Company and who are recommended by the Board of Directors of
the Company for re-election:
Mr. Kevin Melia (Proposed Resolution No. 2(a)).
Dr. Seán Baker (Proposed Resolution No. 2(b)).
Mr. James Maikranz (Proposed Resolution No. 2(c)).
3. To authorize the Audit Committee of the Board Directors
to fix the remuneration of Ernst & Young (Dublin) (the
Auditors) and Ernst & Young LLP (Boston)
(Proposed Resolution No. 3).
4. To consider, and if thought appropriate, pass the
following resolution as a special resolution of the Company
(Proposed Resolution No. 4):
That:
(a) the Company
and/or
any
subsidiary (as such expression is defined by the EC (Public
Limited Companies Subsidiaries Regulations 1997) of the
Company be generally authorized to make market purchases (as
defined by Section 212 of the Companies Act 1990) of
shares of any class of the Company on such terms and conditions
and in such manner as the Directors may from time to time
determine in accordance with and subject to the provisions of
the Companies Act 1990 and to the restrictions and provisions
set out in Article 11(e) of the Articles of Association of
the Company;
(b) the re-issue price range at which any treasury shares
(as defined by Section 209 of the Companies Act
1990) held by the Company may be re-issued off-market shall
be the price range set out in Article 1l(f) of the Articles
of Association of the Company; and
(c) the authorities hereby conferred shall expire at the
close of business (local Irish time) on the earlier of the date
of the next Annual General Meeting of the Company after the
passing of this resolution or January 30, 2010 unless
previously revoked or renewed in accordance with the provisions
of the Companies Act 1990.
The accompanying Proxy Statement contains further information
with respect to these matters.
By Order of the Board of
Directors,
Kevin Melia
Chairman of the Board
Date: April 29, 2008
Registered Office:
The IONA Building
Shelbourne Road
Ballsbridge
Dublin 4 Ireland
WHETHER OR NOT YOU EXPECT TO ATTEND THE ANNUAL MEETING,
PLEASE SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD PROMPTLY IN
ORDER TO ASSURE THAT YOUR SHARES ARE VOTED. A RETURN ENVELOPE IS
ENCLOSED FOR YOUR CONVENIENCE. YOUR PROXY WILL BE AUTOMATICALLY
REVOKED IF YOU VOTE IN PERSON AT THE ANNUAL MEETING.
Notes:
|
|
|
1.
|
|
Pursuant to Regulation 14 of the Companies Act 1990
(Uncertified Securities) Regulations 1996, the Company hereby
specifies that only the holders of record of ordinary shares,
par value 0.0025 per share (Ordinary Shares),
of the Company (individually, Member or
collectively, Members) whose names are registered in
the Register of Members of the Company as of 3:00 p.m. on
September 27, 2008 shall be entitled to attend and vote at
the Annual Meeting in respect of the number of Ordinary Shares
registered in their name at that time. In addition, Members on
the date of the Annual Meeting are entitled to attend and vote
at any adjournment of the Annual Meeting. Only Members as of the
record date (or the close of business on July 18, 2008),
however, will receive notice of the Annual Meeting and any
adjournments thereof.
|
|
2.
|
|
A Member entitled to attend and vote at the Annual Meeting may
appoint a proxy or proxies to attend, speak and vote in his, her
or its place. A proxy does not have to be a Member of the
Company. The form of proxy for use by Members is attached as
Appendix A to this Proxy Statement. To be valid, such
proxies must be lodged with the Secretary of the Company at The
IONA Building, Shelbourne Road, Ballsbridge, Dublin 4, Ireland,
or the Companys Registrar at Computershare Investor
Services (Ireland) Limited, Heron House, Corrig Road, Sandyford
Industrial Estate, Dublin 18, Ireland not less than
48 hours before commencement of the Annual Meeting. In the
event that the Annual Meeting is adjourned to a date that is
less than seven days after the date of the Annual Meeting,
proxies may be deposited with the Secretary of the Company at
the commencement of the adjourned meeting.
|
|
3.
|
|
Holders of the Companys American Depository Receipts
(ADRs) evidencing American Depository Shares
(ADSs) representing our Ordinary Shares may not vote
at the Annual Meeting; however, Deutsche Bank Trust Company
Americas (the Depositary), as depository for the
Ordinary Shares represented by the ADSs, has the right to vote
all of the Ordinary Shares represented by the ADSs, subject to
certain limitations described in this Proxy Statement. For a
more detailed discussion of how holders of ADRs may vote, please
refer to the section titled Voting of Ordinary Shares
Underlying ADSs pursuant to the Deposit Agreement in the
Proxy Statement. The Depositary has set July 18, 2008 as
the record date for the determination of holders of ADRs
entitled to give instructions for the exercise of voting rights
at the Annual Meeting or any adjournment of the Annual Meeting.
A separate proxy card for use by holders of ADRs will be
provided by the Depositary with this Proxy Statement.
|
TABLE
OF CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
4
|
|
|
|
|
5
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
11
|
|
|
|
|
17
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
31
|
|
|
|
|
32
|
|
|
|
|
41
|
|
|
|
|
42
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
A-1
|
|
CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Proxy Statement contains forward-looking statements within
the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995 about our
business and future financial performance. In some cases, you
can identify forward-looking statements by terminology, such as
may, will, should,
could, expect, plan,
anticipate, believe,
estimate, project, predict,
intend, potential, or
continue or the negative of such terms or other
comparable terminology, although not all forward-looking
statements contain such terms. Actual results may differ
materially from those projected in the forward-looking
statements due to various uncertainties and risks, including,
without limitation, risks associated with the effects of general
economic and market conditions, lessening demand in the
information technology market, difficulty managing operations
and difficulty in keeping pace with rapid industry,
technological and market changes, as well as those described in
Item 1A of Part I (Risk Factors) of our Annual Report
on
Form 10-K
for the fiscal year ended December 31, 2007. We disclaim
any obligation to update any forward-looking statements
contained herein after the date of this Proxy Statement.
IONA
TECHNOLOGIES PLC
The IONA Building
Shelbourne Road, Ballsbridge
Dublin 4, Ireland
PROXY
STATEMENT
FOR THE
ANNUAL GENERAL MEETING
To Be
Held on September 29, 2008
INFORMATION
CONCERNING SOLICITATION AND VOTING
Unless otherwise provided herein or required by the context,
references to we, us, our,
the Company or IONA in this Proxy
Statement shall mean IONA Technologies PLC.
General
This Proxy Statement is furnished in connection with the
solicitation by the Board of Directors of IONA Technologies
PLC (the Board of Directors) of proxies for the
Annual General Meeting of IONA (the Annual Meeting)
to be held at The Four Seasons Hotel, Ballsbridge, Dublin 4,
Ireland, on Monday, September 29, 2008, at 3:00 p.m.
(local Irish time), and at any adjournments thereof, for the
purposes set forth in the Notice of Annual General Meeting. This
Proxy Statement, IONAs Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007 (the
Annual Report), IONAs Directors Report
and Consolidated Financial Statements for the fiscal year ended
December 31, 2007, and the accompanying form of proxy are
first being distributed to shareholders on or about
August 8, 2008.
The Directors Report and Consolidated Financial Statements
for the fiscal year ended December 31, 2007 have been
prepared in accordance with applicable Irish law and the
International Financial Reporting Standards (IFRSs)
as adopted by the European Union, and the Companys
financial statements have been prepared in accordance with
applicable Irish law and the Accounting Standards promulgated by
the Accounting Standards Board and published by the Institute of
Chartered Accountants in Ireland (Generally Accepted
Accounting Practice in Ireland). The consolidated
financial statements constitute the Companys statutory
accounts under Irish law and will be annexed to the
Companys annual return to be lodged with the Companies
Registration Office, Dublin, Ireland.
The Annual Report includes financial data and information which
has been prepared in accordance with United States generally
accepted accounting principles (US GAAP). The
financial information included in the Annual Report does not
comprise full accounts within the meaning of Section 19 of
the Companies (Amendment) Act 1986.
The Companys mailing address is The IONA Building,
Shelbourne Road, Ballsbridge, Dublin 4, Ireland, and its
telephone number is +353-1-637-2000.
Record Date for Holders of Ordinary
Shares.
Only holders of record of ordinary
shares, par value 0.0025 per share (Ordinary
Shares), of the Company (individually, Member
and collectively, Members) as of the close of
business on July 18, 2008, whose names are registered in
the Register of Members of the Company will receive notice of
the Annual Meeting and any adjournments thereof; however,
Members as of 3:00 p.m. on September 27, 2008 shall be
entitled to attend and vote at the Annual Meeting in respect of
the number of Ordinary Shares registered in their name at such
time.
Record Date for Holders of ADSs.
Deutsche Bank
Trust Company Americas (the Depositary), as
depositary under the Deposit Agreement dated as of
April 26, 2004 (the Deposit Agreement), among
the Company, the Depositary and the holders of American
Depositary Receipts (ADRs), evidencing American
Depositary Shares (ADSs) representing the Ordinary
Shares, issued thereunder, has fixed the close of business on
July 18, 2008 as the record date for the determination of
holders of ADSs entitled to give instructions for the exercise
of voting rights, in respect of the Ordinary Shares deposited
under the Deposit Agreement, at the Annual Meeting or any
adjournment or postponement thereof.
Shareholder
Meetings
Irish law provides for two types of shareholder meetings, an
annual general meeting and an extraordinary general meeting. An
annual general meeting must be held once every calendar year
within nine months of the end of the fiscal year, provided that
no more than 15 months may elapse between such meetings.
Extraordinary general meetings may be convened by the board of
directors or at the request of shareholders holding not less
than one-tenth of the
paid-up
capital that carries the right of voting at annual general
meetings. Unless all shareholders of the Company and the
Companys independent auditors consent to shorter notice,
shareholders must receive written notice of an annual general
meeting or an extraordinary general meeting convened for the
passing of a special resolution at least 21 clear calendar days
prior to the date of such meeting, and written notice of other
extraordinary general meetings at least 14 clear calendar days
prior to the date of such meeting.
Quorum
and Location of Annual Meeting
A quorum must be present in order to conduct any business at the
Annual Meeting. Our Articles of Association provide that the
presence at the Annual Meeting, either in person or by proxy, of
three persons entitled to vote at such meeting, each being a
Member or a proxy for a Member or a duly authorized
representative of a corporate Member, constitutes a quorum for
the transaction of business. We will treat Ordinary Shares
represented by a properly signed and returned proxy (including
holders of shares who abstain or withhold their vote with
respect to one or more of the proposed resolutions to be voted
on at the meeting) as present at the Annual Meeting for the
purposes of determining the presence or absence of a quorum.
Under Irish law, our Annual Meeting must take place in Ireland,
unless all Members entitled to attend and vote at the meeting
consent in writing to the meeting being held elsewhere or a
resolution providing that the meeting be held elsewhere has been
passed at our previous annual general meeting.
Voting of
Ordinary Shares
Generally.
Voting at the Annual Meeting is by
a show of hands unless a poll (i.e., a written vote) is duly
demanded. Votes may be given either in person or by proxy.
Subject to the Companys Articles of Association and to any
rights or restrictions attached to any class or classes of
shares, by a show of hands each Member present in person or by
proxy has one vote, and on a poll each Member shall have one
vote for each Ordinary Share held by such Member. Where there is
a tie, whether by a show of hands or by a poll, the Chairman of
the meeting is entitled to cast the deciding vote in addition to
any other vote the Chairman may have. A poll may be demanded by
(i) the Chairman of the meeting, (ii) at least five
Members, present in person or by proxy and entitled to vote at
the meeting, (iii) any Member or Members present in person
or by proxy, representing not less than one-tenth of the total
voting rights of all the Members entitled to vote at the
2
meeting, or (iv) any Member or Members present in person or
by proxy holding not less than one-tenth of the
paid-up
capital that carries the right of voting at the meeting. Under
Irish law, an abstention or a vote that is withheld
will not be counted in the calculation of the proportion of the
votes for or against a proposed
resolution.
A majority of votes cast is required to pass an ordinary
resolution, and 75% or greater of the votes cast is required to
pass a special resolution. A special resolution is required to
effect certain actions, including alterations to our Memorandum
or Articles of Association or changes to the name of the
Company. As of March 31, 2008, there were 610 Members
entitled to attend and vote at the Annual Meeting and therefore,
610 votes on a show of hands (or, if a poll is demanded,
36,514,363 votes) capable of being cast at the Annual Meeting.
The number of Members entitled to attend and vote at the Annual
Meeting will be equal to the total number of Members as of
3:00 p.m. on September 27, 2008. The number of votes
capable of being cast at the Annual Meeting will be equal to the
total number of Members on a show of hands (or, if a poll is
demanded, the number of Ordinary Shares in issue) as of
3:00 p.m. on September 27, 2008.
By Proxy.
Each proxy which is properly
executed and returned to the Company will be voted in the manner
directed by the Member executing it or, if no directions are
given, will be voted (or withheld) at the discretion of the
Chairman of the Annual Meeting or any other person duly
appointed as proxy by the Member. The Chairman shall abstain
from voting any proxy for which voting instructions are not
provided.
Any Member who executes and delivers a proxy may revoke it at
any time prior to its use by (i) delivery of a written
notice of such revocation, or a duly executed proxy bearing a
later date to the Secretary of the Company at the address of the
Company set forth above at least 48 hours before
commencement of the Annual Meeting, (ii) appearing at the
Annual Meeting and requesting the return of the proxy, or
(iii) voting at the Annual Meeting. In accordance with the
provisions of the Companys Articles of Association, all
proxies must be received by the Secretary of the Company or the
registrar of the Company at least 48 hours prior to the
Annual Meeting to be validly included in the tally of Ordinary
Shares voted at the Annual Meeting.
Voting of
Ordinary Shares Underlying ADSs pursuant to the Deposit
Agreement
Generally.
Holders of ADRs evidencing ADSs
representing our Ordinary Shares may not vote at the Annual
Meeting; however, subject to certain limitations set forth in
the Deposit Agreement, the Depositary (or more specifically its
nominee, Bank of Ireland Nominees Ltd.) has the right to vote
all Ordinary Shares deposited under the Deposit Agreement. The
Depositary, however, is required by the Deposit Agreement to
vote the Ordinary Shares deposited thereunder in accordance with
the instructions of the holders of ADRs and is prohibited from
exercising voting discretion with respect to such Ordinary
Shares.
Notice of Annual Meeting.
As soon as
practicable after receipt from the Company of the Notice of
Annual General Meeting, the Depositary shall mail to the holders
of ADRs as of the close of business on July 18, 2008 a
notice of the Annual Meeting substantially similar to that sent
to the Members indicating (a) the date, time and place of
the Annual Meeting, (b) that each holder of ADRs on the
close of business on July 18, 2008 will be entitled to
instruct the Depositary as to the exercise of voting rights
pertaining to the Ordinary Shares represented by the ADSs
evidenced by such holders ADRs, and (c) the manner in
which such instructions must be given.
Voting of Ordinary Shares Underlying
ADSs.
Upon the timely receipt of voting
instructions from a holder of ADRs, the Depositary shall vote or
cause to be voted the Ordinary Shares represented by the ADSs
evidenced by such holders ADRs in accordance with such
instructions. Under the Deposit Agreement, the Depository may
give a discretionary proxy to a person designated by the Company
to vote any Ordinary Shares deposited thereunder for which
instructions were either not received or not received on time.
The Depositary itself does not have the right to exercise any
voting discretion with respect to Ordinary Shares deposited
under the Deposit Agreement. The Company, however, has
instructed the Depositary that it does not want a discretionary
proxy to be given to a Company designee with respect to the
matters to be voted upon at the Annual Meeting.
3
Solicitation
of Proxies
The cost of preparing, assembling, printing and mailing the
Proxy Statement, the Notice of Annual General Meeting and the
enclosed form of proxy, as well as the cost of soliciting
proxies relating to the Annual Meeting, will be borne by the
Company. The Company will request banks, brokers, dealers and
voting trustees or other nominees, including the Depositary in
the case of the ADRs, to solicit their customers who are owners
of Ordinary Shares listed of record and names of nominees, and
will reimburse them for the reasonable out-of-pocket expenses of
such solicitation. The original solicitation of proxies by mail
may be supplemented by telephone, telegram and personal
solicitation by officers and other regular employees or agents
of the Company.
Recommendations
of the Board of Directors
The Board of Directors recommends a vote:
|
|
|
|
|
FOR
the proposed resolution to receive and consider the
consolidated financial statements of the Company for the fiscal
year ended December 31, 2007 and the Reports of the
Directors and Auditors thereon (Proposed Resolution 1);
|
|
|
|
FOR
the three nominees listed under Proposed Resolution 2
who retire by rotation pursuant to Article 80(c) of the
Articles of Association of the Company and who are recommended
by the Board of Directors for re-election (Proposed Resolution
2);
|
|
|
|
FOR
approval of the authority of the Audit Committee of
the Board of Directors to fix the remuneration of
Ernst & Young (Dublin) (the Auditors) and
Ernst & Young LLP (Boston) (Proposed
Resolution 3); and
|
|
|
|
FOR
approval of the authority of the Company to purchase
its own shares and set the price range for the re-issue of
treasury shares off-market (Proposed Resolution 4).
|
PROPOSED
RESOLUTION 1
RECEIVE
AND CONSIDER THE CONSOLIDATED FINANCIAL STATEMENTS OF
THE
COMPANY AND THE REPORTS OF DIRECTORS AND AUDITORS
At the Annual Meeting, the consolidated financial statements of
the Company for the fiscal year ended December 31, 2007,
together with the Reports of the Directors and Auditors thereon,
will be presented and considered.
The affirmative vote of a majority of Members present at the
Annual Meeting and voting thereon (or if a poll is demanded at
the meeting, the holders of a majority of the Ordinary Shares
represented at the Annual Meeting and voting thereon) will be
necessary to approve the proposed resolution to receive and
consider the consolidated financial statements of the Company
for the fiscal year ended December 31, 2007 and the Reports
of the Board of Directors and Auditors thereon.
Please note,
however, that a vote FOR or AGAINST this
proposed resolution will have no effect on the approval of the
consolidated financial statements of the Company for the fiscal
year ended December 31, 2007 by the Board of Directors.
Under Irish law, the Company is only obligated to present the
financial statements to the Members at the Annual Meeting, not
submit the financial statements to a vote. Therefore, the
Company will have fulfilled its obligation upon such
presentation regardless of whether or not this vote is
passed.
Ernst & Young (Dublin) reviewed the financial
statements for the fiscal year ended December 31, 2007 as
part of their procedures related to their review and report on
our financial statements for the fiscal year ended
December 31, 2007 prepared in accordance with IFRSs and
Generally Accepted Accounting Practice in Ireland.
Ernst & Young LLP (Boston) audited and reported on our
financial statements for the fiscal year ended December 31,
2007 prepared in accordance with US GAAP.
Representatives of Ernst & Young (Dublin) will be
present at the Annual Meeting to read the Report of the
independent Auditors to the Members and IONA expects that they
will also be available to respond to appropriate questions.
4
The Board of Directors recommends that the shareholders vote
FOR the proposed resolution to receive and consider the
consolidated financial statements of the Company for the fiscal
year ended December 31, 2007 and Reports of the Board of
Directors and Auditors thereon.
PROPOSED
RESOLUTION 2
ELECTION
OF DIRECTORS
Nominees
Pursuant to Article 80(d) of the Companys Articles of
Association, although required to retire by rotation as
directors, Messrs. Kevin Melia and James Maikranz, and
Dr. Seán Baker, all being Class III Directors,
are eligible for re-election. The Board of Directors recommends
their re-election as Class III Directors. If re-elected as
Class III Directors, each director will hold office until
the Companys 2011 annual general meeting unless they
resign or are removed from office, whichever is earlier.
The
affirmative vote of a majority of the Members present at the
Annual Meeting and voting thereon (or, if a poll is demanded at
the meeting, the holders of a majority of the Ordinary Shares
represented at the Annual Meeting and voting thereon) will be
necessary to elect each nominee for Class III Director
.
The Board of Directors is satisfied that each of the nominees
for re-election (i) continues to make an effective
contribution, (ii) demonstrates a commitment to his role as
a director, and (iii) provides an independent and objective
perspective in discharging his duties.
The Board of Directors recommends that the shareholders vote
FOR the re-election of each nominee for Class III
Director.
The following table sets forth (i) the nominees to be
elected at the Annual Meeting, (ii) the other directors,
(iii) the year such nominee or director was first elected a
director, (iv) other positions at IONA currently held by
each nominee or director, (v) the year each nominees
or directors current term will expire and (vi) each
nominees and directors class. Please see the section
titled
Directors and Executive Officers
in
this Proxy Statement for additional information concerning each
of our nominees and continuing directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Current
|
|
|
|
|
|
|
|
|
|
Term as a
|
|
|
Current
|
|
|
|
|
Commencement
|
|
Director will
|
|
|
Class of
|
Name
|
|
Office(s) Held
|
|
of Office
|
|
Expire(1)
|
|
|
Director
|
|
Nominees:
|
|
|
|
|
|
|
|
|
|
|
Kevin C. Melia
|
|
Non-Executive Director Chairman of the Board
|
|
May 1994
May 2003
|
|
|
2008
|
|
|
III
|
Seán Baker
|
|
Non-Executive Director(2)
|
|
October 2007(2)
|
|
|
2008
|
|
|
III
|
James D. Maikranz
|
|
Non-Executive Director
|
|
July 2001
|
|
|
2008
|
|
|
III
|
|
|
|
|
|
|
|
|
|
|
|
Class I Directors:
|
|
|
|
|
|
|
|
|
|
|
Christopher J. Horn
|
|
Non-Executive Director
Vice-Chairman
|
|
March 1991
April 2005
|
|
|
2009
|
|
|
I
|
Bruce J. Ryan
|
|
Non-Executive Director
|
|
June 2006
|
|
|
2009
|
|
|
I
|
|
|
|
|
|
|
|
|
|
|
|
Class II Directors:
|
|
|
|
|
|
|
|
|
|
|
Peter M. Zotto
|
|
Chief Executive Officer Director
|
|
April 2005
April 2005
|
|
|
2010
|
|
|
II
|
Ivor Kenny
|
|
Non-Executive Director
|
|
August 1999
|
|
|
2010
|
|
|
II
|
Francesco Violante
|
|
Non-Executive Director
|
|
May 2001
|
|
|
2010
|
|
|
II
|
|
|
|
(1)
|
|
Unless otherwise indicated, each term will expire on the date of
our annual general meeting in the calendar year listed.
|
|
(2)
|
|
Dr. Baker was an executive director of the Company from
March 1991 to October 2007 when he retired from office as our
Chief Corporate Scientist and became a non-executive director of
IONA.
|
5
PROPOSED
RESOLUTION 3
AUTHORIZATION
OF AUDIT COMMITTEE TO FIX THE REMUNERATION OF
ERNST &
YOUNG (DUBLIN) AND ERNST & YOUNG LLP
(BOSTON)
The remuneration of Ernst & Young (Dublin) and
Ernst & Young LLP (Boston) for the fiscal year ending
December 31, 2008 shall be fixed by the Audit Committee of
the Board of Directors. Neither Ernst & Young (Dublin)
nor Ernst & Young LLP (Boston) has a relationship with
the Company or with any affiliate of the Company, other than as
our auditors.
The affirmative vote of a majority of Members
present at the Annual Meeting and voting thereon (or, if a poll
is demanded at the meeting, the holders of a majority of the
Ordinary Shares represented at the Annual Meeting and voting
thereon) will be necessary to approve the Audit Committees
authority to fix the remuneration of Ernst & Young
(Dublin) and Ernst & Young LLP (Boston)
.
The Board of Directors recommends that the shareholders vote
FOR approval of the Audit Committees authority to fix the
remuneration of Ernst & Young (Dublin) and
Ernst & Young LLP (Boston).
Principal
Accounting Fees and Services for Fiscal Year Ended
December 31, 2007
The following table shows the fees for professional and other
services rendered by Ernst & Young (Dublin) to the
Company during the fiscal years ended December 31, 2007 and
2006:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Audit Fees(1)
|
|
$
|
1,385
|
|
|
$
|
843
|
|
Audit-Related Fees(2)
|
|
|
23
|
|
|
|
20
|
|
Tax Fees(3)
|
|
|
218
|
|
|
|
212
|
|
All Other Fees(4)
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,627
|
|
|
$
|
1,077
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Audit Fees
are fees billed by the auditors
for professional services rendered for the audit of the annual
financial statements or services that are normally provided in
connection with statutory and regulatory filings or engagements,
including the audit of our consolidated and annual financial
statements. Audit Fees also include fees billed for statutory
audits of IONA (including its subsidiaries), the provision of
consents, and the review of documents filed with the U.S.
Securities and Exchange Commission (the SEC).
|
|
(2)
|
|
Audit-Related Fees
consist of the fees billed
by the auditors for assurance and related services that are
reasonably related to the performance of the audit or review of
our financial statements and not reported under Audit
Fees. Audit-Related Fees includes fees for employee
benefit plan audits, consultations concerning financial
accounting and reporting standards, and advisory services
associated with our financial reporting.
|
|
(3)
|
|
Tax Fees
include fees billed by the auditors
for professional services rendered for tax compliance, tax
advice, and tax planning. Tax fees also include fees for the
review, preparation and amending of federal and local tax
returns for the United States, Ireland and other foreign
countries.
|
|
(4)
|
|
All Other Fees
consist of fees for licenses
for accounting research software.
|
Audit
Committees Pre-approval Policies and
Procedures
Our Audit Committee has adopted a pre-approval policy for audit
and non-audit services which sets forth the manner in which
certain proposed services to be performed by our independent
auditor may be pre-approved. Under the policy, the Audit
Committee annually pre-approves a catalog of specific audit and
non-audit services that may be performed by our auditors in the
categories of audit services, audit-related services, tax
services and all other services. Our Audit Committee
pre-approved 100% of the audit and non-audit services performed
by our auditors in 2007 and 2006. In addition, the policy sets
forth an annual budget for
6
each specific cataloged service that may not be exceeded without
obtaining separate pre-approval from the Audit Committee.
Pursuant to the policy, any proposed service not pre-approved
under a catalog or any proposal to exceed the allotted budget
must be submitted to the Audit Committee for approval at the
next scheduled meeting of the Audit Committee. In the event that
time constraints necessitate pre-approval prior to the next
scheduled meeting of the Audit Committee, the Chairman of the
Audit Committee has the authority to grant such pre-approval.
The Chief Financial Officer is responsible for monitoring the
services of the independent auditor, determining whether such
services are in compliance with the policy, and periodically
reporting the results of such services to the Audit Committee.
The Chief Financial Officer or any other executive officer is
required to immediately report any breach of the policy to the
Chairman of the Audit Committee.
PROPOSED
RESOLUTION 4
AUTHORITY
OF THE COMPANY TO PURCHASE ITS OWN SHARES
AND TO
SET PRICE RANGE FOR RE-ISSUE OF TREASURY SHARES
OFF-MARKET
At last years annual general meeting, our shareholders
authorized the Company to purchase up to 10% of our own shares
and set the price range at which treasury shares may be
re-issued off-market. This authority will expire on the day of
the Annual Meeting. At the Annual Meeting, we will propose to
renew this authorization for an additional 18 months, or
until the next annual general meeting, whichever is earlier.
The affirmative vote of 75% of the Members present at the
Annual Meeting and voting thereon (or if a poll is demanded at
the meeting, the holders of 75% of the Ordinary Shares
represented at the Annual Meeting and voting thereon) will be
necessary to approve the Companys authority to purchase
its own shares and set the price range for the re-issue of
treasury shares off-market
.
The Board of Directors recommends that the shareholders vote
FOR approval of the authority of the Company to purchase of its
own shares and set the price range for the re-issue of treasury
shares off-market.
7
DIRECTORS
AND EXECUTIVE OFFICERS
The following table sets forth our directors and executive
officers, their ages and the positions currently held by each
such person at IONA as of April 15, 2008.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Nominees:
|
|
|
|
|
|
|
Kevin C. Melia
|
|
|
60
|
|
|
Chairman of the Board
|
Seán Baker+
|
|
|
49
|
|
|
Non-Executive Director
|
James D. Maikranz*+
|
|
|
61
|
|
|
Non-Executive Director
|
|
|
|
|
|
|
|
Class I Directors:
|
|
|
|
|
|
|
Christopher J. Horn
|
|
|
51
|
|
|
Vice Chairman of the Board
|
Bruce J. Ryan
|
|
|
64
|
|
|
Non-Executive Director
|
|
|
|
|
|
|
|
Class II Directors:
|
|
|
|
|
|
|
Peter M. Zotto+
|
|
|
63
|
|
|
Chief Executive Officer and Director
|
Ivor Kenny*
|
|
|
78
|
|
|
Non-Executive Director
|
Francesco Violante*
|
|
|
57
|
|
|
Non-Executive Director
|
|
|
|
|
|
|
|
Other Executive Officers:
|
|
|
|
|
|
|
Lawrence E. Alston, Jr.
|
|
|
46
|
|
|
Vice President and General Manager, Open Source
|
Scott R. Devens
|
|
|
45
|
|
|
Vice President of Worldwide Sales
|
Christopher M. Mirabile
|
|
|
41
|
|
|
Chief Financial Officer, General Counsel and Secretary
|
Eric A. Newcomer
|
|
|
53
|
|
|
Chief Technology Officer
|
|
|
|
|
|
Member of Audit Committee
|
|
*
|
|
Member of Compensation Committee
|
|
|
|
Member of Nominating and Corporate Governance Committee
|
|
+
|
|
Member of New Markets Committee
|
Set forth below is information with respect to (i) each
nominee for Class III Director to be elected at the Annual
Meeting, (ii) the Class I and II Directors, and
(iii) the other executive officers.
Information
With Respect to Nominees
Kevin C. Melia
has served as our Chairman of the Board
since May 2003 and as a non-executive director from May 1994 to
May 2003. Mr. Melia served as Chairman of the Board of
Manufacturers Services Limited, an electronics
manufacturing outsourcing company from January 2002 to January
2003. From June 1994 to January 2002, Mr. Melia served as
Chief Executive Officer of Manufacturers Services Limited.
From January 1992 to June 1994, he was Chief Financial Officer
of Sun Microsystems, a workstation manufacturer. In addition,
from January 1993 to February 1994, Mr. Melia was President
of Sun Microsystems Computer Co., a division of Sun
Microsystems. Mr. Melia currently serves on the board of
directors of RadiSys Corp., a
U.S.-based
provider of embedded advanced solutions for the communications
networking and commercial systems markets, Greatbatch, Inc., a
CRM and medical device manufacturer, and C&S Wholesale
Grocers, Inc., a
U.S.-based
wholesale grocery distributor. He is also currently serving as a
joint managing director of Boulder Brook Partners LLC, a
U.S.-based
private investment firm.
Seán Baker
served as our Chief Corporate Scientist
from May 2003 to October 2007 and as an executive director from
March 1991 to October 2007 when he retired from office as our
Chief Corporate Scientist and became a non-executive director.
Dr. Baker co-founded IONA in March 1991, and served as
Senior Vice President from 1991 to 1996, as Executive Vice
President, Customer Services from 1996 to 1999, as Chief
Scientific Officer from 1999 to November 2000, as Executive Vice
President and Chief Technology Officer
8
from November 2000 to September 2001, and as Chief Corporate
Officer from September 2001 to May 2003. From 1981 to 1994,
Dr. Baker held a tenured post in the Computer Science
Department at Trinity College, Dublin. Dr. Baker currently
serves on the board of directors of National Digital Research
Centre Limited, an Irish based technology research and
innovation company. He formed and is
co-director
of CIO Ireland, and he is a member of the Advisory Science
Council, the Executive Committee of the Irish Software
Association, and the Advisory Board Irish Centre for High-End
Computing. Dr. Baker also chairs the R&D Advisory
Committee to the ICT Sector within ICT Ireland.
James D. Maikranz
has served as a non-executive director
of IONA since July 2001. Mr. Maikranz was employed by J.D.
Edwards & Company, a provider of collaborative
software solutions, from October 1998 to March 2001, most
recently as Senior Vice President of Worldwide Sales. Prior to
joining J.D. Edwards & Company, Mr. Maikranz was
employed by SAP AG, a provider of
e-business
software solutions, from January 1992 to September 1998, most
recently as Senior Vice President of Sales. Mr. Maikranz
has also served in senior executive positions for Computer
Application Specialists, a software company specializing in the
oil and gas industry, and Info Services, a company providing
human resources based software applications. Mr. Maikranz
was a founder and member of the board of directors of the
Chaptec Solutions Company, a management consulting firm.
Mr. Maikranz has been an advisory board member for
i2 Technologies, Inc., a supply chain optimization company,
and currently serves on the board of directors of Servigistics,
Inc., a global service parts management solutions company, Taleo
Corporation (formerly known as Recruitsoft, Inc.), a provider of
on demand talent management solutions, and DataSynapse, Inc., a
grid computing software application company.
Information
with respect to Class I Directors
Christopher J. Horn
has served as our Vice Chairman of
the Board of Directors since April 2005. Dr. Horn
co-founded IONA in February 1991 and served as our Chief
Executive Officer from the Companys inception through May
2000, and then again from May 2003 to September 2005.
Dr. Horn also served as Chairman of the Board from February
1991 to May 2003. He is best known for his development of
IONAs Orbix product. Dr. Horn received his Doctorate
in Computer Science from Trinity College, Dublin. Dr. Horn
currently serves as a director for the charitable organization
UNICEF Ireland, UUTECH, the University of Ulsters
technology and knowledge transfer company, Cloudsmith Inc., a
U.S.-based
software tooling company, Sli Siar Teoranta, an Irish-based
business consultancy company and LeCayla Technologies Limited,
an Irish-based software billing systems company. Dr. Horn
received an honorary Doctor of Science from Trinity College,
Dublin and the Gold Medal for Industry from the Industry and
Commerce Committee of the Royal Dublin Society in 2001.
Bruce J. Ryan
has served as a non-executive director of
IONA since June 2006. From November 2003 to June 2004,
Mr. Ryan served as the Interim Chief Executive Officer of
Silverstorm Technologies, Inc., a networking technology company.
From February 1998 to November 2002, Mr. Ryan served as
Executive Vice President and Chief Financial Officer of Global
Knowledge Network Training LLC, a provider of information
technology learning services and certifications, and from July
1994 to October 1997, he served as the Executive Vice President
and Chief Financial Officer of Amdahl Corporation, a provider of
information technology solutions. In addition, from 1969 to
1994, Mr. Ryan held various executive positions at Digital
Equipment Corporation, including Senior Vice President of
Financial Services, Senior Vice President of Industry Marketing
and Vice President and Corporate Controller. Mr. Ryan also
currently serves on the board of directors of UTStarcom
Incorporated and KVH Industries, Inc., and is the chairman of
KVHs audit committee.
Information
with respect to Class II Directors
Ivor Kenny
has served as a non-executive director of IONA
since August 1999. Dr. Kenny has written thirteen books on
strategic leadership, for one of which he was awarded a DLitt
and Outstanding Doctor of the Year. He is currently a director
of the Irish-based international media group Independent News
and Media PLC and chairman of its compensation committee, and
Distinguished Professor of Public Policy at International
Management Centres. From 1982 to November 2006, Dr. Kenny
served as Senior Research Fellow at University College Dublin,
where he worked with international organizations on their
strategies. He was Director General of the Irish Management
Institute from 1962 to 1983, Chancellor of the International
9
Academy of Management from 1982 to 1987,
Executive-in-Residence
at Indiana University in 1986 and a Fulbright Fellow at American
Universities. He holds a number of distinctions and honorary
doctorates and was invested a Knight Commander of the Order of
St. Gregory by Pope John Paul II. He was awarded the Gold Medal
of Honor of the Comité International de lOrganisation
Scientifique and the First Economics Award of the Economic
Development Foundation, Texas.
Francesco Violante
has served as a non-executive director
of IONA since May 2001. Since June 2006, Mr. Violante has
served as Chief Executive Officer of the SITA Group, a
Swiss-based global airline reservation systems company.
Mr. Violante served as Regional Vice President of
Electronic Data Systems Corp. Europe from October 2000 to May
2003. From May 2003 to June 2006, Mr. Violante served as
Managing Director of SITA, Inc., and as its Senior Vice
President, from October 1999 to September 2000.
Mr. Violante served as Chief Information Officer of Telecom
Italia SpA, an Italian telephone company, from September 1998 to
October 1999. Prior to September 1998, Mr. Violante held
numerous executive management positions at Compaq Corporation,
Europe and Digital Equipment Corporation.
Peter M. Zotto
has served as our Chief Executive Officer
and a director since April 2005. Mr. Zotto served as our
Chief Operating Officer from October 2003 to April 2005 and as
our President from October 2004 to April 2005. Prior to joining
IONA, Mr. Zotto was the Chief Executive Officer of Proteus
Industries, Inc., a life sciences company, from January 2003 to
August 2003. Mr. Zotto is the founder of Claright, a
consulting firm specializing in providing marketing expertise to
small to mid-sized companies, and served as its President from
April 2001 to October 2002. From September 1999 to March 2001,
Mr. Zotto was Chief Executive Officer of WBT Systems, Inc.,
an
e-learning
software company. Mr. Zotto held a number of executive
management positions at Digital Equipment Corporation from 1992
though 1999, including General Manager and Vice President,
Workstations Business, Vice President, European Sales and
Marketing and General Manager, Systems Business Unit.
Information
with respect to Other Executive Officers
Lawrence E. Alston, Jr.
has served as our Vice
President and General Manager of Open Source since May 2007.
From January 2007 to May 2007, Mr. Alston served as our
Vice President of Corporate Strategy and Product Management, and
from May 2004 to January 2007, he served as our Vice President
of Marketing. Prior to joining IONA, Mr. Alston served as
Vice President, Products of Pantero Corporation, a
U.S.-based
data interoperability solutions company, from March 2003 to May
2004. Mr. Alston served as Vice President of Product
Management and Strategy from 2000 to 2002 at eXcelon Corporation
(formerly known as Object Design, Inc.), a
U.S.-based
software infrastructure, products, services and solutions
company, and prior to that held various positions in product
management and marketing at eXcelon Corporation from 1993 to
2000.
Scott R. Devens
has served as our Vice President of
Worldwide Sales since January 2008. From January 2007 to January
2008, Mr. Devens served as our Vice President of
International Sales and Alliances, where he was responsible for
overseeing the Companys sales activities in Europe, the
Middle East, Africa, and the Asia-Pacific Rim, and for managing
strategic alliances with platform and technology providers and
system integrators. He served as our Vice President of
Asia-Pacific and Alliances from March 2005 to January 2007, as
our Vice President of Products from March 2004 to March 2005,
and as our Vice President of our CORBA Business Unit from April
2003 to March 2004. Prior to joining IONA, Mr. Devens had a
14-year
tenure at Data General Corporation (now part of EMC
Corporation), where he served as General Manager of Latin
America among other senior management positions in finance and
operations.
Christopher M. Mirabile
was appointed as our Chief
Financial Officer in January 2008 and has served as our General
Counsel and Secretary since September 2003. Mr. Mirabile
served as our Senior Counsel from 1997 to 2000 and as our
Corporate Counsel from 2000 until 2003. Prior to joining IONA,
Mr. Mirabile was a lawyer in the business practice group at
Testa, Hurwitz & Thibeault, LLP of Boston,
Massachusetts. Prior to beginning his legal practice,
Mr. Mirabile was a management consultant with Price
Waterhouse LLP in its Strategic Consulting Group.
Eric A. Newcomer
has served as our Chief Technology
Officer since April 2002. From November 1999 to March 2002,
Mr. Newcomer served as our Vice President of Engineering,
Web Services Integration Products.
10
Prior to joining IONA, Mr. Newcomer was a Senior Member of
Technical Staff and Manager of the COM+ Expertise Center,
Enterprise Application Server Engineering, NT Program Office, at
Digital Equipment Corporation/Compaq Computer Corporation from
October 1997 to October 1999. Mr. Newcomer is a co-author
of
Understanding SOA with Web Services
published in
December 2004 by Addison Wesley
,
author of
Understanding Web Services
published in May 2002 by
Addison Wesley, co-author of
Principles of Transaction
Processing
published in January 1997 by Morgan Kaufman and
the author
and/or
co-author of numerous whitepapers and articles.
Our executive officers are appointed by the Board of Directors
on an annual basis and serve until their resignation, retirement
or removal, whichever is earlier.
CORPORATE
GOVERNANCE AND BOARD MATTERS
Independence
of Members of the Board of Directors
The Board of Directors has determined that Dr. Kenny and
Messrs. Maikranz, Melia, Ryan and Violante are independent
within the meaning of the director independence standards of
Rule 4200(a)(15) of the National Association of Securities
Dealers (NASD), the NASDAQ Stock Market LLC listing
standards (NASDAQ), and the SEC, including
Rule 10A-3(b)(1)
under the Securities Exchange Act of 1934, as amended (the
Exchange Act). In determining the independence of
directors, the Board of Directors broadly considers all relevant
facts and circumstances, including relationships, if any, set
forth in this Proxy Statement under the section titled
Certain Relationships and Related
Transactions.
Board
Meetings
During the fiscal year ended December 31, 2007, the Board
of Directors held eight meetings. Each incumbent director
attended no fewer than 75% of the board meetings held during
such period. In addition, each incumbent director, other than
Mr. Maikranz, attended no fewer than 75% of the meetings of
the committees of the Board of Directors on which he served
during such period. For the 2007 fiscal year, Mr. Maikranz
attended 71% of the Audit Committee meetings and 67% of the
Compensation Committee meetings held during the period in which
he was a member of such committee. Mr. Maikranz was unable
to participate in certain meetings due to business conflicts.
Attendance
at the Annual General Meeting
Our policy is to schedule a regular meeting of the Board of
Directors on the same date as our annual general meeting and,
accordingly, directors are encouraged to be present at our
annual general meeting as well. All of the directors attended
our annual general meeting held in 2007.
Committees
of the Board of Directors
The Board of Directors has established four standing committees:
the Audit Committee, the Compensation Committee, the Nominating
and Corporate Governance Committee and the New Markets
Committee. The membership of each committee is listed below.
|
|
|
|
|
|
|
|
|
|
|
Nominating and
|
|
|
Audit
|
|
Compensation
|
|
Corporate Governance
|
|
New Markets
|
|
Bruce J. Ryan, Chairman
|
|
Ivor Kenny, Chairman
|
|
Kevin C. Melia, Chairman
|
|
James D. Maikranz, Chairman
|
James D. Maikranz
|
|
Francesco Violante
|
|
Bruce J. Ryan
|
|
Peter M. Zotto
|
Kevin C. Melia
|
|
James D. Maikranz
|
|
Ivor Kenny
|
|
Seán Baker
|
Audit
Committee
During the fiscal year ended December 31, 2007, the Audit
Committee held eight meetings and took no actions by unanimous
written consent. This committee operates under a written charter
adopted by the Board of Directors, a current copy of which is
available under the corporate governance section of our website
at
11
www.iona.com
. The Audit Committee reviews with management
and our auditors our financial statements, the accounting
principles applied in the preparation of our financial
statements, the scope of the audit, any comments made by the
auditors on our financial statements and our accounting controls
and procedures, our worldwide corporate compliance program, the
independence of our auditors, our internal controls, our policy
pertaining to related person transactions, the other matters as
set forth in the committees charter, as adopted by the
Board of Directors, and such other matters as the committee
deems appropriate. The Audit Committee is directly responsible
for the appointment, compensation, retention and oversight of
the work of our independent auditors in preparing or issuing an
audit report or performing other audit, review or attest
services for us and pre-approves all such audit, review or
attest engagements. The Audit Committee also approves all audit
and non-audit fees to be paid, and non-audit services to be
performed, by our auditors and is responsible for preparing the
Audit Committee Report for inclusion in this and subsequent
proxy statements in accordance with applicable rules and
regulations.
The Board of Directors has determined that each member of the
Audit Committee is independent within the meaning of the
director independence standards of NASDAQ and applicable rules
of the SEC, including
Rule 10A-3(b)(1)
under the Exchange Act, and that each member is financially
literate and has the requisite financial sophistication required
by the NASD audit committee requirements. In addition, the Board
of Directors has determined, in accordance with the rules of the
SEC, that Mr. Ryan is an audit committee financial
expert. Shareholders should understand that this
designation is a disclosure requirement of the SEC related to
Mr. Ryans experience and understanding with respect
to certain accounting and auditing matters. The designation does
not impose upon Mr. Ryan any duties, obligations or
liability that are greater than those that are generally imposed
on other members of the Audit Committee and the Board of
Directors, and designation as an audit committee financial
expert pursuant to this SEC requirement does not affect the
duties, obligations or liability of any other member of the
Audit Committee or the Board of Directors.
Compensation
Committee
During the fiscal year ended December 31, 2007, the
Compensation Committee held 15 meetings and took no actions by
unanimous written consent. This committee operates under a
written charter adopted by the Board of Directors, a current
copy of which is available under the corporate governance
section of our website at
www.iona.com
. The Compensation
Committee sets our executive compensation philosophy and
objectives; authorizes the retention and termination of outside
advisors used for compensation matters and determines the scope
of their assignments; recommends compensation for our directors,
executive officers and employees; reviews and approves the goals
and objectives relevant to the compensation of our executive
officers and evaluates their performance, including performance
relative to respective goals and objectives, as well as overall
performance; monitors all general compensation programs; and
reviews and recommends for inclusion in our annual proxy
statement the section titled Compensation Discussion and
Analysis. The Compensation Committee is also responsible
for the administration and award of equity incentives pursuant
to our equity incentive plans and administration of our 1999
Employee Share Purchase Plan.
In determining the appropriate compensation of our executive
officers, the Compensation Committee uses compensation survey
data from executive compensation surveys, the consulting
services of Radford Surveys & Consulting
(Radford) to provide analysis of the various
components of the compensation of our executive officers against
industry benchmarks, and, solely in connection with the
compensation of the executive officers other than the Chief
Executive Officer, the analysis and recommendations of the Chief
Executive Officer. Please see the section titled
Compensation Discussion and Analysis
in this
Proxy Statement for a more detailed discussion of our
compensation philosophy, objectives, practices and analysis.
The Board of Directors has determined that each member of the
Compensation Committee is (i) an independent director
within the meaning of the director independence standards of
NASDAQ and applicable rules of the SEC; (ii) a non-employee
director as defined in
Rule 16b-3
of the Exchange Act; and (iii) an outside director pursuant
to Rule 162(m) of the Internal Revenue Code.
12
Compensation
Committee Interlocks and Insider Participation
No member of the Compensation Committee has ever been an officer
or employee of IONA or any of its subsidiaries. None of our
executive officers serves as a member of the board of directors
or compensation committee of any entity that has an executive
officer serving as a member of our Board of Directors or
Compensation Committee.
Nominating
and Corporate Governance Committee
During the fiscal year ended December 31, 2007, the
Nominating and Corporate Governance Committee held five meetings
and took action by unanimous written consent four times. This
committee operates under a written charter adopted by the Board
of Directors, a current copy of which is available under the
corporate governance section of our website at
www.iona.com
. The Board of Directors has determined that
each member of the Nominating and Corporate Governance Committee
is independent within the meaning of the director independence
standards of NASDAQ and applicable rules of the SEC.
The Nominating and Corporate Governance Committee reviews the
composition, size and organization of the Board of Directors and
establishes criteria and procedures for identifying and
evaluating candidates for our Board of Directors. This committee
annually reviews its charter, as well as the criteria and
procedures for identifying and evaluating director candidates.
The Nominating and Corporate Governance Committee identifies
candidates for our Board of Directors through numerous sources,
including recommendations from the other directors, the Chief
Executive Officer, other executive officers, third-party search
firms, shareholders or any other source it deems appropriate.
This committee will evaluate all proposed director candidates in
the same manner, with no regard to the source of the initial
recommendation. It seeks to have available to it qualified
candidates from a broad pool of individuals with a range of
talents, experience, backgrounds and perspectives. This
committee considers many factors with regard to each candidate,
including judgment, integrity, diversity, prior experience, the
interplay of the candidates experience with the experience
of other members of the Board of Directors, and the
candidates willingness to devote substantial time and
effort to board responsibilities. At a minimum, the Nominating
and Corporate Governance Committee must be satisfied that each
nominee meets the following minimum qualifications:
|
|
|
|
|
The nominee shall have experience at a strategic or policymaking
level in a business, government, non-profit or academic
organization of high standing.
|
|
|
|
The nominee shall be highly accomplished in his or her
respective field, with superior credentials and recognition.
|
|
|
|
The nominee shall be well regarded in the community and shall
have a long-term reputation for high ethical and moral standards.
|
|
|
|
The nominee shall have sufficient time and availability to
devote to the affairs of the Company, particularly in light of
the number of boards on which the nominee may serve.
|
Based on the foregoing, the Nominating and Corporate Governance
Committee makes recommendations to the Board of Directors with
respect to director nominees.
Process
for Shareholders to Nominate Candidates to our Board of
Directors
A. Shareholders may nominate a candidate to our Board of
Directors by submitting written notice of such nomination to the
Secretary of the Company not later than the close of business on
the seventh
(7
th
)
day nor earlier than the close of business on the forty-second
(42
nd
)
day prior to the date selected for a general meeting of the
shareholders. All such shareholder nominations for director
candidates must include the following information:
|
|
|
|
|
Name and address of the shareholder making the nomination, as it
appears in the Register of Members of the Company, or if the
shareholder is not a Member, evidence of ownership in accordance
with
Rule 14a-8(b)(2)
of the Exchange Act;
|
13
|
|
|
|
|
Name, age, residential address, nationality and current
principal occupation or employment of the individual nominated
and particulars of any other corporate directorships, whether
incorporated in Ireland or elsewhere, held by that individual or
which have been held by him/her; and
|
|
|
|
The nominated candidates written consent to serve as a
director if elected at such meeting.
|
B. In addition, shareholders who wish to submit a
nomination to our Nominating and Corporate Governance Committee
for its review and possible inclusion in our proxy statement for
our next annual general meeting must follow the following
procedures:
1. Recommendations must be submitted to the Secretary of
the Company not less than 120 calendar days prior to the date on
which the Companys proxy statement was released to
shareholders in connection with the previous years annual
meeting.
2. Recommendations must include the following information:
|
|
|
|
|
The name and address of record of the shareholder making the
recommendation.
|
|
|
|
A representation that the shareholder is a record holder of the
Companys securities, or if the shareholder is not a record
holder, evidence of ownership in accordance with
Rule 14a-8(b)(2)
of the Exchange Act.
|
|
|
|
The name, age, business and residential address, educational
background, current principal occupation or employment, and
principal occupation or employment for the preceding five full
fiscal years of the proposed director candidate.
|
|
|
|
A description of the qualifications and background of the
proposed director candidate which addresses the minimum
qualifications and other criteria for Board membership approved
by the Board from time to time and set forth in our Nominating
and Corporate Governance Committees charter.
|
|
|
|
A description of all arrangements or understandings between the
shareholder and the proposed director candidate.
|
|
|
|
The consent of the proposed director candidate (i) to be
named in the proxy statement relating to the Companys
annual general meeting and (ii) to serve as a director if
elected at such annual meeting.
|
|
|
|
Any other information regarding the proposed director candidate
that is required to be included in a proxy statement filed
pursuant to the rules of the SEC.
|
Our Secretary will promptly forward such nominations to the
Nominating and Corporate Governance Committee. Once the
Nominating and Corporate Governance Committee receives the
nomination of a candidate and the shareholder making the
nomination has complied with the minimum procedural requirements
above, the Nominating and Corporate Governance Committee will
evaluate such candidate for possible recommendation to our Board
of Directors for candidacy to our Board of Directors.
C. All nominations pursuant to sections A and B above
must be sent to the attention of the Secretary of the Company at:
IONA Technologies PLC
The IONA Building
Shelbourne Road
Ballsbridge, Dublin 4
Ireland
New
Markets Committee
During the fiscal year ended December 31, 2007, the New
Markets Committee held two meetings and took no action by
unanimous written consent. The New Markets Committee assesses
potential new strategic
14
markets, including vertical market opportunities, potential
strategic and financial partners and potential strategic market
initiatives, as well as any other matters as the Board of
Directors may delegate to it from time to time.
Communications
with the Non-Executive Directors
The Board of Directors provides a process for our shareholders
to send communications directly to our non-executive directors.
Any shareholder who desires to contact the non-executive
directors may do so by writing to IONA Non-Executive Directors
c/o IONA
Technologies PLC, The IONA Building, Shelbourne Road,
Ballsbridge, Dublin 4, Ireland.
All communications received will be forwarded directly to the
Nominating and Corporate Governance Committee, who will forward
such communications to other non-executive directors, members of
IONAs management or such other persons as it deems
appropriate. The Nominating and Corporate Governance Committee
or, if appropriate, IONAs management, will respond in a
timely manner to any substantive communications from a
shareholder or an interested party.
Code of
Business Conduct and Ethics
It is our policy that all of our officers, directors and
employees worldwide conduct our business in an honest and
ethical manner and in compliance with all applicable laws and
regulations. Our Board of Directors adopted a Code of Business
Conduct and Ethics that applies to all of our directors,
officers and employees, including our Chief Executive Officer,
Chief Financial Officer and Corporate Controller. This code was
filed as Exhibit 11.1 to our Annual Report on
Form 20-F
for the year ended December 31, 2003 and is available on
our website at
www.iona.com
. You may also obtain a copy
of our Code of Business Conduct and Ethics free of charge by
contacting our Investor Relations department at our
U.S. headquarters as follows: IONA Technologies, Inc.,
200 West Street, Waltham, Massachusetts 02451 or
781-902-8000.
This code satisfies the requirements set forth in Item 406
of
Regulation S-K
and applies to all relevant persons set forth therein. We intend
to disclose on our website at
www.iona.com
amendments to,
and, if applicable, waivers of, our Code of Business Conduct and
Ethics.
Policies
and Procedures Regarding Review, Approval or Ratification of
Related Party Transactions
The Nominating and Corporate Governance Committee has adopted a
written policy for the review, approval and ratification of
transactions involving the Company and related
persons (directors, director nominees, executive officers,
or shareholders beneficially owning more than 5% of our Ordinary
Shares, and the immediate family members of such persons). The
policy covers all transactions, arrangements or relationships
(or any series of similar transactions, arrangements or
relationships) in which the Company or any of its subsidiaries
was, is or will be a participant, and in which any related
person had, has or will have a direct or indirect material
interest.
All related person transactions are reviewed and, as
appropriate, may be approved or ratified by the Nominating and
Corporate Governance Committee
and/or
the
Board of Directors. If a director is involved in the
transaction, he or she may not participate in any review,
approval or ratification of such transaction. Related person
transactions are approved by the Nominating and Corporate
Governance Committee
and/or
the
Board of Directors only if, based on all of the facts and
circumstances, they are in, or not inconsistent with, the best
interests of the Company and our shareholders, as the Nominating
and Corporate Governance Committee
and/or
the
Board of Directors determines in good faith. In the case of a
transaction presented to the Nominating and Corporate Governance
Committee
and/or
the
Board of Directors for ratification, the Nominating and
Corporate Governance Committee
and/or
the
Board of Directors may ratify the transaction or determine
whether rescission of the transaction is appropriate.
15
Certain
Relationships and Related Transactions
In accordance with its charter, the Nominating and Corporate
Governance Committee conducts a review of all related party
transactions for potential conflict of interest situations on an
ongoing basis, and, if appropriate, approves all related party
transactions.
Other than compensation agreements and other arrangements which
are described in the section titled
Compensation
Discussion & Analysis
in this Proxy
Statement, and payments made to K Capital Source Limited
(K Capital) described below, in 2007, there was no
transaction or series of similar transactions to which we were a
party in which the amount involved exceeded $120,000 in which
any director, executive officer, holder of 5% or more of any
class of our capital stock, or any member of their immediate
family had a direct or indirect material interest.
The Company engaged K Capital to provide capital market
communication and advisory services in 2007 and paid K Capital
$180,000 for such services. A son of Dr. Ivor Kenny, a
member of our Board of Directors, was a principal of K Capital
during part of 2007. Prior to December 31, 2007, Financial
Dynamics Ireland Limited acquired K Capital. As a result, from
and after December 31, 2007, Dr. Kennys son no
longer has an equity interest in the company providing capital
market communication and advisory services to the Company.
16
REPORT OF
THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
No portion of this Report of the Audit Committee shall be
deemed to be incorporated by reference into any filing under the
Securities Act of 1933, as amended (the Securities
Act), or the Exchange Act through any general statement
incorporating by reference in its entirety the Proxy Statement
in which this report appears, except to the extent that the
Company specifically incorporates this report or a portion of it
by reference. In addition, this report shall not be deemed filed
under either the Securities Act or the Exchange Act.
This report is submitted by the Audit Committee of the Board of
Directors. The Audit Committee currently consists of
Messrs. Ryan (chairman), Maikranz and Melia. None of the
members of the Audit Committee is an officer or employee of the
Company, and the Board of Directors has determined that each
member of the Audit Committee meets the independence
requirements promulgated by NASDAQ and the SEC, including
Rule 10A-3(b)(1)
under the Exchange Act. Mr. Ryan is an audit
committee financial expert as currently defined under SEC
rules. The Audit Committee operates under a written charter
adopted by the Board of Directors.
The Audit Committee oversees the Companys accounting and
financial reporting processes on behalf of the Board of
Directors. The Companys management has the primary
responsibility for the financial statements, for maintaining
effective internal control over financial reporting, and for
assessing the effectiveness of internal control over financial
reporting. In fulfilling its oversight responsibilities, the
Audit Committee has reviewed and discussed with management the
Companys audited consolidated financial statements for the
fiscal year ended December 31, 2007, including a discussion
of, among other things, the quality of the Companys
accounting principles, the reasonableness of significant
estimates and judgments, and the clarity of disclosures in the
Companys financial statements.
The Audit Committee also reviewed with Ernst & Young
(Dublin), the Companys independent auditors, the results
of their audit and discussed matters required to be discussed by
the Statement on Auditing Standards No. 61
(Communication with Audit Committees)
, as currently in
effect, other standards of the Public Company Accounting
Oversight Board, rules of the SEC and other applicable
regulations. The Audit Committee has reviewed permitted services
under rules of the SEC as currently in effect and discussed with
Ernst & Young (Dublin) its independence from
management and the Company, including the matters in the written
disclosures and the letter from the independent auditors
required by Independence Standards Board Standard No. 1
(
Independence Discussions with Audit Committees
), as
currently in effect, and has considered and discussed the
compatibility of non-audit services provided by
Ernst & Young (Dublin) with that firms
independence.
The Audit Committee met with Ernst & Young (Dublin),
with and without management present, to discuss the results of
its examination; its evaluation of the Companys internal
controls, including internal control over financial reporting;
and its assessment of the overall quality of the Companys
financial reporting.
Based on its review of the financial statements and the
aforementioned discussions, the Audit Committee concluded that
it would be reasonable to recommend, and on that basis did
recommend, to the Board of Directors that the audited
consolidated financial statements be included in the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2007 for filing with the
SEC.
The Audit Committee has also evaluated the performance of
Ernst & Young (Dublin), including, among other things,
the amount of fees paid to Ernst & Young (Dublin) for
audit and non-audit services in 2007. Information about the fees
paid to Ernst & Young (Dublin) in 2007 is discussed in
this Proxy Statement under Proposed Resolution
3
Authorization of the Audit Committee to fix the
Remuneration of Ernst & Young (Dublin) and
Ernst & Young LLP (Boston).
Respectfully submitted by the Audit Committee,
Bruce J. Ryan,
Chairman
James D. Maikranz
Kevin C. Melia
17
NAMED
EXECUTIVE OFFICERS
Our named executive officers for the fiscal year ended
December 31, 2007 are Peter M. Zotto, Chief Executive
Officer; Robert C. McBride, Chief Financial Officer until
January 31, 2008; and the other three most highly
compensated executive officers: William B. McMurray, Vice
President, World Wide Sales and Marketing until January 1,
2008; Lawrence E. Alston, Jr., Vice President and General
Manager, Open Source; and Christopher M. Mirabile, General
Counsel and Secretary. Mr. Mirabile was appointed as our
Chief Financial Officer effective February 1, 2008 and
retains the titles of General Counsel and Secretary. These
individuals are referred to collectively in this Proxy Statement
as our Named Executive Officers.
COMPENSATION
AND OTHER INFORMATION CONCERNING DIRECTORS AND
OFFICERS
Compensation
Discussion and Analysis
Overview
This Compensation Discussion and Analysis
(CD&A) discusses our overall compensation
philosophy, objectives and practices for our Named Executive
Officers, with an emphasis on the analysis used to determine the
total compensation of our Named Executive Officers.
Our compensation philosophy is based on a desire to balance
retention of executive talent with pay for performance-based
incentive compensation. Our incentive compensation programs are
designed to reward our Named Executive Officers for continued
service and our sustained financial and operating performance.
We believe that the compensation of our Named Executive Officers
should align their interests with those of our shareholders and
focus their behavior on the achievement of short-term corporate
targets as well as long-term business objectives and strategies.
It is the responsibility of the Compensation Committee of our
Board of Directors, which is comprised entirely of directors who
are independent under the standards established by NASDAQ and
the SEC, to establish and administer our compensation practices
to ensure that these practices are competitive and include
incentives designed to appropriately drive our performance.
Objectives
of Our Compensation Program for Named Executive
Officers
Our compensation program for our Named Executive Officers is
designed to achieve the following objectives:
|
|
|
|
|
to align our executives interests with those of our
shareholders;
|
|
|
|
to provide competitive compensation that attracts, motivates and
retains the most talented executives of the highest caliber to
help us to achieve our strategic objectives;
|
|
|
|
to connect a portion of the total potential compensation paid to
our Named Executive Officers to our annual financial
performance, or the performance of the division, region or
segment of our business for which an executive has management
responsibility, by tying short-term and long-term incentive
compensation to corresponding financial targets; and
|
|
|
|
to provide management with performance goals that are directly
linked to our annual plan for growth and profit.
|
While we generally believe that the compensation of our Named
Executive Officers should reflect their success as a management
team, rather than as individuals, in attaining short-term and
long-term key operating objectives (such as revenue growth and
gross profit improvement), as well as longer-term strategic
objectives (such as product development), we also believe that
individual performance and success should be rewarded. Our cash
incentives are structured to reward achievement of short and
long-term team, as well as and individual, performance
objectives.
We also believe that the compensation of our Named Executive
Officers should not be based on the short-term performance of
our Ordinary Shares, whether favorable or unfavorable, but
rather on our long-term operating performance. We believe that
the price of our Ordinary Shares over time will reflect our
long-term operating performance and, ultimately, the quality of
the management of the Company by our Named
18
Executive Officers. Therefore, we seek to have our long-term
performance reflected in our executive compensation through our
equity incentive programs, which are designed to align the
interests of our Named Executive Officers with those of our
shareholders.
In setting compensation levels for our Named Executive Officers
for the fiscal year ended December 31, 2007, the
Compensation Committee considered the following factors, in
addition to the benchmarking described below under
Role
of Benchmarking and Compensation Consultant in Compensation
Decisions
:
|
|
|
|
|
the scope and strategic impact of the Named Executive
Officers responsibilities;
|
|
|
|
our past business performance and future expectations;
|
|
|
|
our long-term goals and strategies;
|
|
|
|
the performance, experience and tenure of each Named Executive
Officer;
|
|
|
|
past salary levels of each individual and of our Named Executive
Officers as a group;
|
|
|
|
relative levels of pay among our Named Executive Officers;
|
|
|
|
the total mix of compensation components; and
|
|
|
|
the competitiveness of the compensation packages relative to the
benchmark data.
|
The Compensation Committee believes that our analysis of these
factors, in conjunction with the benchmarking data, provides the
best information to structure the compensation of our Named
Executive Officers to meet our compensation objectives.
Role
of Benchmarking and Compensation Consultant in Compensation
Decisions
The Compensation Committee believes that the use of benchmarking
data is an important factor in remaining competitive with our
peers and furthering our objective of attracting, motivating and
retaining highly qualified personnel. To gauge market
competitiveness of our Named Executive Officer compensation, the
Compensation Committee typically utilizes (i) compensation
survey data from highly regarded executive compensation surveys
for the software and high technology and the subscription
software industries and (ii) the consulting services of
Radford. For the fiscal year ended December 31, 2007, at
the recommendation of the Vice-President of Human Resources, the
Compensation Committee used the following surveys to review the
compensation of our Named Executive Officers:
|
|
|
|
|
the Radford High Technology Executive Survey, a survey of
software companies with revenues between $40 million and
$199 million;
|
|
|
|
the Radford High Technology Executive Survey, a survey of high
technology companies with revenues between $50 million and
$199 million; and
|
|
|
|
the Culpepper Executive Survey, a survey of software companies
with revenues between $50 million and $199 million.
|
The Compensation Committee believes that the practices of the
companies within these industries and revenue ranges provide us
with the appropriate compensation benchmarks because these
companies have similar organizational structures and tend to
compete with us to attract executives and other employees. The
Compensation Committee, with the assistance of our Vice
President of Human Resources, annually reassesses the relevance
of these surveys and makes appropriate changes as necessary.
Role
of the Chief Executive Officer in Compensation
Decisions
The Compensation Committee, which is comprised entirely of
directors who are independent under the standards established by
NASDAQ and the SEC, determines the compensation packages for all
of our Named Executive Officers. In determining the appropriate
compensation for our Named Executive Officers other than the
Chief Executive Officer, the Compensation Committee will meet
with our Chief Executive Officer and our Vice-President of Human
Resources to review the analysis provided by Radford, and
determine the appropriate
19
compensation of such executive officers. Our Chief Executive
Officer does not participate in any discussions concerning his
own compensation.
In the first quarter of each year, our Chief Executive Officer
will meet with each executive officer to establish such
officers performance objectives for the current fiscal
year and evaluate the performance of each executive officer
against such officers performance objectives from the
prior fiscal year. Performance objectives are generally aligned
to (i) IONAs operating plan as approved by the Board
of Directors, (ii) the performance objectives approved by
the Compensation Committee for the Chief Executive Officer, and
(iii) individual goals. Using the results of these
performance assessments, combined with the results from the
compensation benchmarking process, our Chief Executive Officer,
with information provided by our Vice-President of Human
Resources, makes recommendations to the Compensation Committee
regarding the base salaries, variable compensation components,
and long term incentive equity awards for the other Named
Executive Officers. The Compensation Committee then carefully
considers these recommendations when setting the overall
compensation for each Named Executive Officer for the next
fiscal year.
In addition to his recommendations, but subject to compensation
parameters approved by the Compensation Committee, our Chief
Executive Officer has the discretion to set certain management
by objective targets for certain bonus awards to our executive
officers under our Senior Management Team Bonus Plan. These
bonuses are generally accretive to any incentive award
established by the Compensation Committee and the targets are
generally aligned to IONAs operating plan and goals for
the Chief Executive Officer as approved by the Board of
Directors.
Elements
of Compensation
Our executive compensation program consists of three primary
elements: base salary, cash incentives and long-term equity
incentives, primarily in the form of share options and
performance based phantom share unit awards. Our Named Executive
Officers are also eligible for certain benefits offered to
employees generally, including life, health, disability and
dental insurance, as well as the right to participate in our
401(k) plan. Our Named Executive Officers are generally at
will employees, except for our Chief Executive Officer,
who has a three-year employment contract that is discussed in
more detail under the section titled
Potential Benefits
Upon Termination or Change in Control
of this Proxy
Statement. In addition, we entered into change in control
agreements with our Named Executive Officers, and have a change
in control plan for our non-executive directors, both of which
provide severance and other benefits to our Named Executive
Officers and directors in the event of a change in control of
the Company, and are discussed in more detail in this CD&A.
|
|
|
|
|
Base Salary
: We provide an annual salary to
each Named Executive Officer as an economic consideration for
each persons level of responsibility, expertise, skills,
knowledge and experience, as well as the length of time with the
Company.
|
|
|
|
Variable Cash Compensation
: Cash bonuses are
part of our variable compensation and are used for short-term
incentives. We have three forms of awards:
|
|
|
|
|
|
Type of Award
|
|
Performance Period
|
|
Performance Criteria
|
|
Annual Cash Bonus
|
|
1 year
|
|
Based on our revenue and operating income targets and individual
performance metrics
|
Annual Sales Commission
|
|
1 year
|
|
Based on our revenue targets
|
Discretionary Cash Bonus
|
|
Discretionary
|
|
Based on individual performance
|
|
|
|
|
|
Equity Incentives
: Under our 2006 Share
Incentive Plan, we may award both incentive and non-qualified
share options, share appreciation rights, restricted share
awards, unrestricted share awards, performance based phantom
share units and other performance based awards to our Named
Executive Officers and directors. To date, the Compensation
Committee has awarded only share options and phantom share units
to our Named Executive Officers as a form of variable
compensation that provides incentives to build long-term
shareholder value, to align the interests of our Named Executive
Officers and shareholders, and to retain our Named Executive
Officers through what we hope will be long-term wealth creation
in the value of their share options or phantom share units
through potential share price appreciation above the exercise or
grant price of the options or phantom share units, respectively.
The
|
20
|
|
|
|
|
amount of any income earned is dependent upon and varies with
the share price over the vesting term. Our ability to award
other types of long-term equity incentives other than share
options became available in 2006 after the adoption of the
2006 Share Incentive Plan. Since that time, the
Compensation Committee has decided that performance based
phantom share units should represent a proportion of the long
term incentives granted to Named Executive Officers because it
believes that this type of award provides the best tool
available to the Company to link performance criteria to
long-term equity incentives. The SEC requires that we report the
estimated fair value of our share option grants in the
Summary Compensation Table
and the
Grants of Plan-Based Awards Table
in this
Proxy Statement in accordance with Financial Accounting Standard
No. 123R for accounting purposes. At the time of grant, our
share options have no intrinsic value and the amounts disclosed
in the tables for accounting purposes do not reflect whether the
executive officer has or will realize a financial benefit from
the share option awards. Actual value realized for fiscal year
2007 upon the exercise of share options or the vesting of
phantom share units is identified in the
Option
Exercises and Stock Vested Table
of this Proxy
Statement.
|
|
|
|
|
|
Employee Share Purchase Plan
: Our 1999
Employee Share Purchase Plan is a tax-qualified, voluntary
employee share purchase plan, available to all employees,
including our Named Executive Officers. Under this plan, our
employees may purchase shares for 85% of the lower of:
(1) the fair market value on the first day of the six-month
offering period or (2) the fair market value on the last
day of the six-month offering period. The 1999 Employee Share
Purchase Plan encourages long-term share ownership and helps to
align employee and shareholder interests on a cost- and
tax-effective basis. Under the plan each employee may purchase a
maximum of 1,000 shares in each six-month offering period.
|
|
|
|
401(k) Plan
: We offer a tax-qualified 401(k)
plan to all U.S. domestic employees, including our Named
Executive Officers. We match employee contributions up to a
maximum of $6,600 in order to encourage employee participation.
|
|
|
|
Health and Welfare Programs
: We offer all
U.S. domestic employees, including our Named Executive
Officers, health, dental and vision insurance.
|
|
|
|
Insurance
: We provide company-paid life
insurance to all U.S. domestic employees, including our
Named Executive Officers, equal to annual salary subject to a
minimum of $50,000 and maximum of $300,000.
|
|
|
|
Vacation
: We also offer a vacation program to
all employees, including our Named Executive Officers, that is
consistent with competitive practices in our industry. The
vacation accrual rate varies with the Named Executive
Officers length of service to the Company.
|
|
|
|
Potential Benefits Upon a Change in
Control
: We have entered into change in control
agreements, as amended, with each of our Named Executive
Officers and have a change in control plan for non-executive
directors, as amended, which provide for certain benefits upon a
change in control of the Company. See the section titled
Potential Benefits Upon Termination of Employment or a
Change in Control
in this Proxy Statement
for a more detailed discussion of such benefits.
|
|
|
|
Severance Benefits
: We do not have a
pre-defined severance policy for the involuntary termination of
our employees. Except as may be set forth in any employment or
change in control agreements, no Named Executive Officer is
entitled to receive any severance upon
his/her
involuntary termination. In addition, generally upon the
involuntary termination of employment, a Named Executive Officer
will have 30 days to exercise the vested portion of any
share options
he/she
may
hold. However, this period is extended to one year in the case
of termination of employment as a result of a Named Executive
Officers disability, death or retirement. Except in the
case of death, in each of these circumstances, all unvested
options automatically expire. In the case of death, all unvested
options accelerate and become fully exercisable for the
remainder of the option term. Further, in the event of an
involuntary for cause termination, all unvested and
vested share options automatically expire.
|
21
Share
Incentive Plans
The following is a brief description of each of our share option
plans under which our Named Executive Officers have been granted
equity incentives.
2006 Share
Incentive Plan
On May 10, 2006, the Board of Directors adopted our
2006 Share Incentive Plan and on August 24, 2006, it
was approved by our shareholders. The 2006 Share Incentive
Plan replaces the Companys 1997 Share Option Scheme
and 1997 Director Share Option Scheme, both of which have
been terminated and no additional options may be granted
thereunder.
Certain features of the 2006 Share Incentive Plan include:
|
|
|
|
|
The exercise price per share for the shares covered by a share
option granted pursuant to the 2006 Share Incentive Plan
may not be less than 100% of the fair market value of our
Ordinary Shares on the date of grant. In the case of an
incentive share option that is granted to employee holding more
than 10% of our total combined voting power at the time of the
grant, the exercise price of such incentive share option may be
not less than 110% of the fair market value of our Ordinary
Shares on the date of grant. Further, share options granted
under the 2006 Share Incentive Plan expire ten years from
the date of grant or five years from the date of grant in the
case of an incentive share option granted to an employee holding
more than 10% of our total combined voting power at the time of
the grant.
|
|
|
|
The maximum number of shares that may be issued under the
2006 Share Incentive Plan is the sum of (i) 4,000,000
Ordinary Shares, plus (ii) shares subject to awards
outstanding under the 1997 Share Option Scheme and
1997 Director Share Option Scheme that are subsequently
forfeited, cancelled, held back upon exercise of an option or
settlement of an award to cover the exercise price or tax
withholding, reacquired by the Company prior to vesting,
satisfied without the issuance of shares or otherwise terminated
(other than by exercise).
|
|
|
|
No more than 25% of shares issued under the 2006 Share
Incentive Plan may be awarded as incentive options. Each share
subject to unrestricted share awards, restricted share awards or
phantom share units will be considered to be the equivalent of
1.5 shares subject to a share option for purposes of
calculating the maximum share limit.
|
In the Compensation Committees discretion, awards with
conditions and restrictions relating to the attainment of
performance goals may become vested and non-forfeitable in
connection with a change in control. In addition, in the event
of a change in control of the Company in which our shareholders
will receive cash consideration, the Company may make or provide
for a cash payment to participants holding share options and
share appreciation rights equal to the difference between the
per share cash consideration and the exercise price of the share
options or share appreciation rights.
1997 Director
Share Option Scheme
All share options granted under the 1997 Director Share
Option Scheme automatically accelerate and become exercisable in
full in the event the option holders service on our Board
of Directors ceases by reason of his death or permanent
disability or in the event of a change in control of IONA.
1999
Employee Share Purchase Plan
In 1999, the Company established a qualified Employee Share
Purchase Plan. In 2003, the Board of Directors and shareholders
approved an amendment to the 1999 Employee Share Purchase Plan
to increase the number of our Ordinary Shares issuable under the
plan to 2,000,000. All of the Companys employees and
employees of the Companys participating subsidiaries who
are employed full-time on the first and last business day of any
payment period (a six-month period commencing February 1 and
August 1 and ending July 31 and January 31, respectively,
in each year) and have worked for more than five months in any
calendar year are eligible to participate. The purchase price
per Ordinary Share for each payment period is the lesser of
22
(i) 85% of the average market price of our ADSs on the
first business day of the payment period and (ii) 85% of
the average market price of our ADSs on the last business day of
the payment period. In each payment period, an employee may
authorize payroll deductions in an amount not less than 1% but
not more than 10% of the employees salary for
participation in the 1999 Employee Share Purchase Plan. Rights
under the 1999 Employee Share Purchase Plan terminate upon the
happening of certain specified events including retirement,
resignation and death.
Senior
Management Team Bonus Plan
The Senior Management Team Bonus Plan provides for annual target
bonus amounts for our executive officers, including our Named
Executive Officers, based upon the attainment of performance
targets that are established by the Compensation Committee for
the relevant fiscal year, and relate to financial metrics with
respect to the Company or any of its subsidiaries, including,
but not limited to, the following: revenue, operating income and
specific strategic operational goals for the relevant fiscal
year. The plan also provides that each Named Executive Officer
who is eligible to receive a bonus under the plan shall have a
targeted bonus opportunity for each performance period. Pursuant
to the plan, performance goals are measured at the end of each
performance period after the Companys financial reports
have been released.
Impact
of Tax and Accounting on Compensation Decisions
As a general matter, the Compensation Committee takes into
account the various tax and accounting implications of the
compensation vehicles employed by us.
When determining amounts of long-term incentive grants to
executives and employees, the Compensation Committee examines
the accounting cost associated with the grants. Under
FAS 123(R), grants of share options and restricted share
units result in an accounting charge for us equal to the grant
date fair value of those securities. For restricted share units,
the accounting cost is generally equal to the fair market value
of the underlying shares of common stock on the date of the
award. The cost is then amortized over the requisite service
period. With respect to share options, we calculate the grant
date fair value based on the Black-Scholes formula with an
adjustment for possible forfeitures and amortize that value as
compensation expense over the vesting period.
Section 162(m) of the Internal Revenue Code does not permit
publicly traded companies to take income tax deductions for
compensation paid to the Chief Executive Officer and certain
other executive officers to the extent that compensation exceeds
$1 million per officer in any taxable year and does not
otherwise qualify as performance-based compensation. The
Compensation Committee considers steps that might be in the
Companys best interests to minimize the impact of
Section 162(m) of the Internal Revenue Code. However, in
establishing the cash and equity incentive compensation programs
for our Named Executive Officers, the Compensation Committee
believes that the potential deductibility of the compensation
payable under those programs should be only one of a number of
relevant factors taken into consideration, and not the sole or
primary factor. The Compensation Committee believes that cash
and equity incentive compensation must be maintained at the
requisite level to attract and retain the executive officers
essential to the Companys financial success, even if all
or part of that compensation may not be deductible by reason of
the limitations of Section 162(m) of the Internal Revenue
Code.
Compensation
Mix
When making compensation decisions, the Compensation Committee
analyzes summaries prepared by Radford of the prior years
base salary, short-term incentives and long-term incentives for
each Named Executive Officer. The summaries present the dollar
amount of the following components of the Named Executive
Officers compensation: base salary, target cash bonuses
versus actual cash bonuses earned, and the value of outstanding
equity awards. In addition, Radford provides analysis of the
various components of the compensation of our Named Executive
Officers against industry benchmarks. Taking into account the
recommendations provided by the Chief Executive Officer, the
Compensation Committee then considers the appropriate
compensation mix as between base and variable compensation for
each Named Executive Officer.
23
In 2007, between 20% and 40% of the total compensation for our
Named Executive Officers, other than the Vice-President of
Worldwide Sales and Marketing, was represented by variable
compensation. In 2007, 60% of the total compensation for the
Vice-President of Worldwide Sales and Marketing was represented
by variable compensation. The Compensation Committee believes
that this compensation mix was required in order motivate and
retain our Named Executive Officers in an extremely competitive
environment.
Base
Salary
The Compensation Committee believes that our Named Executive
Officers, including our Chief Executive Officer, are paid
salaries in line with their responsibilities, expertise, skills,
knowledge and experience. The Compensation Committee targets
base salaries for each of our Named Executive Officers at
between the market median
(50
th
percentile)
and upper quartile
(75
th
percentile)
for the software and high technology industries, as identified
in the compensation surveys described above. We believe that
this target enables us to attract, motivate and retain our
leadership team in an extremely competitive environment. In
general, the salaries of our Named Executive Officers are
reviewed on an annual basis.
Mr. Zottos base salary for the 2007 fiscal year was
$375,000 (which amount reflects the annualized dollar amount of
Mr. Zottos base salary based on an
April 1
st
start
date of his employment contract with the Company). The
Compensation Committee determined the amount of the Chief
Executive Officers base salary based on the following
factors: (i) the Companys strong financial
performance for the 2006 fiscal year, (ii) the positive
evaluation by the Board of Directors of his overall performance
in the 2006 fiscal year, (iii) the operating plan and goals
set for him by the Board of Directors for the 2007 fiscal year;
and the Compensation Committees assessment that his base
salary for the 2006 fiscal year was below the market median
salary for chief executive officers of software companies with
revenues in the range of $40 million to $199 million,
as identified in the compensation surveys described above. The
Compensation Committee believed that in order to retain
Mr. Zotto, it was appropriate to position his base salary
between the market median
(50
th
percentile)
and upper quartile
(75
th
percentile)
for the software and high technology industries, as identified
in the compensation surveys described above.
The base salaries for our other Named Executive Officers were
determined by the Compensation Committee after considering
(i) their then current base salary level,
(ii) benchmark salary information; (iii) the
Companys strong financial performance for the 2006 fiscal
year, (iv) their individual performance assessments for the
2006 fiscal year; (v) salary recommendations from our Chief
Executive Officer, and (vi) the amount of base salary as a
component of total compensation. The Compensation Committee also
took into account the competitive environment for attracting and
retaining executives for similar positions in the software
industry. The Compensation Committee determined that although
the Company has a strong financial performance in the 2006
fiscal year, the base salaries for each of these Named Executive
Officers were competitive at between the market median
(50
th
percentile)
and upper quartile
(75
th
percentile)
in the software and high technology industries, as identified in
the compensation surveys described above, and therefore did not
need to be changed for the 2007 fiscal year from the levels
established for the 2006 fiscal year. For the fiscal years 2006
and 2007, the base salaries for our Named Executive Officers
were:
|
|
|
|
|
|
|
|
|
|
|
Base Salary ($)
|
|
Name
|
|
2006
|
|
|
2007
|
|
|
Peter M. Zotto(1)
|
|
|
350,000
|
|
|
|
375,000
|
|
Robert C. McBride
|
|
|
250,000
|
|
|
|
250,000
|
|
William B. McMurray
|
|
|
300,000
|
|
|
|
300,000
|
|
Lawrence E. Alston Jr.
|
|
|
252,000
|
|
|
|
252,000
|
|
Christopher M. Mirabile
|
|
|
260,000
|
|
|
|
260,000
|
|
|
|
|
(1)
|
|
Represents the annualized dollar amount of Mr. Zottos
base salary based on an
April 1
st
start date of his employment contract with the Company.
|
Variable
Cash Compensation
The Compensation Committee believes that some portion of overall
cash compensation for executive officers should be at
risk, or contingent upon successful implementation of the
Companys overall strategy. For
24
the 2007 fiscal year, pursuant to the Senior Management Team
Bonus Plan, the Compensation Committee established a bonus
program for our senior management team (the 2007 Senior
Management Team Bonus Program), including our Named
Executive Officers other than our Named Executive Officers who
were covered by a sales commission plan. Mr. McMurray, and
for part of the year, Mr. Alston, were not eligible to
receive a bonus under this program because they were covered by
a sales commission plan. Mr. Alston was eligible to
participate in the program only for that portion of the year
where he did not have a sales commission plan. The annual target
cash bonus amounts for the participants under this program were
aimed to be between the market median
(50
th
percentile)
and upper quartile
(75
th
percentile)
of bonuses awarded to executive officers in the software and
high technology industries, as identified in the compensation
surveys described above. The 2007 fiscal year annual target
bonus amounts, as well as amounts actually paid, for the
participants were:
|
|
|
|
|
|
|
|
|
|
|
2007 Senior Management Team Bonus Program
|
|
|
|
2007
|
|
|
2007
|
|
|
|
Target Bonus
|
|
|
Bonus
|
|
Name
|
|
Amount ($)
|
|
|
Paid ($)
|
|
|
Peter M. Zotto
|
|
|
250,000
|
|
|
|
|
|
Robert C. McBride
|
|
|
100,000
|
|
|
|
|
|
Lawrence E. Alston Jr.
|
|
|
42,000
|
|
|
|
|
|
Christopher M. Mirabile
|
|
|
75,000
|
|
|
|
|
(1)
|
|
|
|
(1)
|
|
Mr. Mirabile was awarded a $25,500 discretionary bonus in
connection with his work on two acquisitions completed by the
Company in 2007.
|
For purposes of the 2007 Senior Management Team Bonus Program,
the financial performance of our Company for the 2007 fiscal
year was measured quarterly based on the achievement of certain
revenue and operating income targets, and individual performance
criteria was based on each individuals area of
responsibility. Although the Compensation Committee structured
the program so that Company and individual performance criteria
were weighted equally in order to stress the importance of both
group and individual performance, a performance threshold based
upon the attainment of certain Company performance targets was
established. In cases where the Company fails to meet the
overall Company performance metrics, no bonuses would be
awarded. The Company performance metrics and bonus amounts were
evaluated as follows:
|
|
|
|
|
A matrix was created for the 2007 fiscal year based on the 2007
operating plan approved by the Board of Directors. The x axis
contained Company revenue targets and the y axis contained
Company operating income targets.
|
|
|
|
The threshold revenue target for the 2007 fiscal year was
$80.0 million and the threshold operating income target for
the 2007 fiscal year was $4.0 million. The target revenue
for the 2007 fiscal year was $85.0 million and the target
operating income for the 2007 fiscal year was $8.5 million.
|
|
|
|
If the threshold Company revenue and operating income targets
were met, depending on the Companys performance on a
sliding scale between the threshold and target revenue and
operating income targets, participants would be eligible for
between 25% and 100% of their target bonus amount. However,
failure of the Company to meet either the threshold revenue
target or the threshold operating income target would result in
each participant being ineligible to receive any bonus.
Participants were eligible to receive bonuses in excess of their
bonus target amounts if the Companys revenue and operating
income exceeded the targets. Amounts awarded would have been
determined at the discretion of the Compensation Committee.
|
|
|
|
Participants were eligible for only 40% of their total annual
target bonus for the first half of the 2007 fiscal year.
Participants were eligible for the remaining 60% of their total
annual target bonus and any overachievement amount for the
second half of the 2007 fiscal year.
|
The threshold Company revenue or operating income targets for
the 2007 fiscal year, as determined under the 2007 Senior
Management Team Bonus Program, were not met, and therefore, no
bonuses were awarded. However, based on the recommendation of
our Chief Executive Officer, the Compensation Committee decided
25
to award a $25,500 discretionary bonus to Mr. Mirabile in
connection with his work in 2007 related to the acquisitions of
two companies, Century 24 Solutions Limited and Logicblaze, Inc.
The Compensation Committee also established a sales commission
program for Mr. McMurray based on our 2007 operating plan,
which paid sales commissions based on the achievement of global
quarterly and annual revenue quotas for the 2007 fiscal year.
The quotas were set for global product, consulting, training and
support revenues based on the overall Company revenue target of
$85.0 million, as outlined in our 2007 operating plan as
approved by the Board of Directors. Within parameters set by the
Compensation Committee, our Chief Executive Officer established
the matrix pursuant to which Companys actual results were
measured and commissions paid. For the 2007 fiscal year,
Mr. McMurrays target bonus amount was $250,000. If
Company revenue targets were achieved for each of these
categories, then Mr. McMurray would receive 100% of his
target bonus amount. If actual aggregate revenue was greater
than the total quota amount, then Mr. McMurray was eligible
to receive a bonus in excess of the $250,000 target. Any excess
amount awarded was determined by the Compensation Committee in
its discretion. Mr. McMurray was paid $197,509 under this
program.
In addition to his sales commission program and in accordance
with the discretion afforded to our Chief Executive Officer
under the 2007 Senior Management Team Bonus Program, our Chief
Executive Officer established an additional management by
objectives (MBO) bonus opportunity of $210,000 for
Mr. McMurray in order to incentivize him to exceed the
quarterly revenue targets set forth in his sales commission
program. For each quarter where revenues exceeded the target by
a certain percentage, Mr. McMurray had the opportunity to
earn the following bonus amounts: $35,000 for the first quarter,
$70,000 for the second quarter, $70,000 for the third quarter,
and $35,000 for the fourth quarter. The quarterly bonus
opportunities are cumulative such that bonus amounts for
quarters where revenue targets were missed were eligible to be
awarded if the revenue target in a future quarter was
overachieved such that the aggregate of the quarterly revenue
targets to that date were achieved. Mr. McMurray was
awarded $175,000 of the entire $210,000 opportunity.
The Compensation Committee also established a bonus program for
Mr. Alston based on our 2007 operating plan, which paid
sales commissions based on the achievement of global quarterly
and annual billing goals for the 2007 fiscal year. Billing goals
were established for our open source business against which
actual results were measured and commission awarded. For the
2007 fiscal year, Mr. Alstons target bonus amount was
$63,000. If the Companys billing goals were achieved, then
Mr. Alston would receive 100% of his target bonus amount.
If the actual billings were greater than the goal assigned, then
Mr. Alston was eligible to receive a bonus in excess of the
$63,000 target. Mr. Alston was paid $63,000 under this
program.
Equity
Incentives
In the 2007 fiscal year, the Compensation Committee awarded two
types of long-term equity incentives to our Named Executive
Officers share options and phantom share units. The
Compensation Committee believed that the granting of these
long-term equity incentives was necessary in order motivate and
retain our Named Executive Officers in an extremely competitive
environment. In prior years, all of our long-term equity
incentives were structured as share options that vested over
time. Based on industry analysis and consultation with Radford,
the Compensation Committee decided that a portion of the
long-term equity incentives awarded to our Named Executive
Officers should be contingent upon the successful achievement of
certain Company performance criteria. Therefore, the
Compensation Committee decided to grant a combination of share
options and performance-based phantom share units to our Named
Executive Officers.
26
In February 2007, the Compensation Committee awarded the
following share options to our Named Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
Share Options
|
|
|
|
Number of
|
|
|
Exercise
|
|
|
|
Shares Subject
|
|
|
Price per
|
|
Name
|
|
to Option
|
|
|
Share ($)
|
|
|
Peter M. Zotto
|
|
|
75,000
|
|
|
|
5.33
|
|
Robert C. McBride
|
|
|
|
|
|
|
|
|
William B. McMurray
|
|
|
30,000
|
|
|
|
5.33
|
|
Lawrence E. Alston Jr.
|
|
|
25,000
|
|
|
|
5.33
|
|
Christopher M. Mirabile
|
|
|
25,000
|
|
|
|
5.33
|
|
In addition, in February 2007, the Compensation Committee
awarded phantom share units to our Named Executive Officers.
These phantom share units had two requirements for vesting:
(i) the satisfaction of certain Company performance-based
objectives and (ii) the passage of time. The Compensation
Committee aligned the Company performance metrics to be the same
as the metrics used for the 2007 Senior Management Bonus
Program. The Company performance metrics and the number of
phantom share units that could vest is as follows:
|
|
|
|
|
A matrix was created for the 2007 fiscal year based on the 2007
operating plan approved by the Board of Directors. The x axis
contained Company revenue targets and the y axis contained
Company operating income targets.
|
|
|
|
The threshold revenue target for the 2007 fiscal year was
$80.0 million and the threshold operating income target for
the 2007 fiscal year was $4.0 million. The target revenue
for the 2007 fiscal year was $85.0 million and the target
operating income for the 2007 fiscal year was $8.5 million.
|
|
|
|
If the threshold Company revenue and operating income targets
were met, depending on the Companys performance on a
sliding scale between the threshold and target revenue and
operating income targets, between 30% and 100% of an award would
vest over time from the date of grant. If the target revenue and
operating income targets were exceeded, depending on the
Companys total performance on a sliding scale, up to a
maximum of 120% of an award would vest over time from the date
of grant. However, if the Company failed to meet either the
threshold revenue target or the threshold operating income
target, the phantom share units would automatically expire.
|
|
|
|
The purchase price per share upon the vesting of the phantom
share units is 0.0025 or par value per share.
|
The following table sets forth the number of phantom share units
that (i) could have been earned by each Named Executive
Officer if (A) the threshold and target performance
objectives were achieved and (B) the maximum number of
units were awarded, and (ii) were earned. As set forth in
the
Grants of Plan-Based Awards Table
in this
Proxy Statement, the threshold Company revenue and operating
income targets for the 2007 fiscal year were not met and
therefore, no phantom share units were eligible to vest and all
of the units automatically expired.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Phantom Share Units Granted
|
|
|
|
Under 2006 Share Incentive Plan
|
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Number of
|
|
|
|
Number of
|
|
|
Number of
|
|
|
Number of
|
|
|
Phantom
|
|
|
|
Phantom
|
|
|
Phantom
|
|
|
Phantom
|
|
|
Share Units
|
|
Name
|
|
Share Units
|
|
|
Share Units
|
|
|
Share Units
|
|
|
Earned
|
|
|
Peter M. Zotto
|
|
|
12,450
|
|
|
|
41,450
|
|
|
|
49,800
|
|
|
|
|
|
Robert C. McBride
|
|
|
9,900
|
|
|
|
33,000
|
|
|
|
39,600
|
|
|
|
|
|
William B. McMurray(1)
|
|
|
12,450
|
|
|
|
41,500
|
|
|
|
49,800
|
|
|
|
|
|
Lawrence E. Alston Jr.
|
|
|
4,200
|
|
|
|
14,000
|
|
|
|
16,800
|
|
|
|
|
|
Christopher M. Mirabile
|
|
|
4,200
|
|
|
|
14,000
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
(1)
|
|
Represents the aggregate number of phantom share units that
Mr. McMurray was eligible to receive.
|
27
Executive
Compensation Summary
The following table sets forth summary compensation information
for our Named Executive Officers for the fiscal year ended
December 31, 2007.
SUMMARY
COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
Share
|
|
Option
|
|
Incentive Plan
|
|
Compensation
|
|
All Other
|
|
|
Name and Principal
|
|
Fiscal
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Earnings
|
|
Compensation
|
|
Total
|
Position
|
|
Year(1)
|
|
($)
|
|
($)
|
|
($)(2)
|
|
($)(3)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Peter M. Zotto
|
|
|
2007
|
|
|
|
368,750
|
|
|
|
|
|
|
|
|
|
|
|
492,244
|
|
|
|
|
|
|
|
|
|
|
|
11,011
|
(4)
|
|
|
872,005
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert C. McBride
|
|
|
2007
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
230,000
|
|
|
|
|
|
|
|
|
|
|
|
7,011
|
(4)
|
|
|
487,011
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William B. McMurray
|
|
|
2007
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
281,025
|
|
|
|
372,509
|
(5)
|
|
|
|
|
|
|
39,847
|
(4)
|
|
|
993,381
|
|
Vice-President,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide Sales and Marketing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence E. Alston, Jr.
|
|
|
2007
|
|
|
|
252,000
|
|
|
|
|
|
|
|
|
|
|
|
222,975
|
|
|
|
63,000
|
(6)
|
|
|
|
|
|
|
7,011
|
(4)
|
|
|
544,986
|
|
Vice-President and General Manager, Open Source
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher M. Mirabile
|
|
|
2007
|
|
|
|
260,000
|
|
|
|
25,500
|
(7)
|
|
|
|
|
|
|
145,185
|
|
|
|
|
|
|
|
|
|
|
|
7,011
|
(4)
|
|
|
437,696
|
|
General Counsel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The fiscal year in this column refers to the fiscal year ended
December 31, 2007.
|
|
(2)
|
|
No share awards were granted in 2007 to our Named Executive
Officers.
|
|
(3)
|
|
This column represents the dollar amount recognized for
financial statement reporting purposes in accordance with
FAS 123R for fiscal year 2007 for share option awards
granted to each of our Named Executive Officers in fiscal year
2007 as well as in prior fiscal years, and does not reflect
whether the recipient has actually realized a financial benefit
from the awards (such as by exercising share options). Pursuant
to SEC rules, the amounts shown exclude the impact of estimated
forfeitures related to service-based vesting conditions. No
share option awards were forfeited by any of our Named Executive
Officers in fiscal year 2007. There can be no assurance that the
FAS 123R amount will ever be realized. For additional
information, see the notes to our financial statements in our
Annual Report on
Form 10-K
for the year ended December 31, 2007, as filed with the
SEC. For information on the valuation assumptions for grants
made prior to fiscal year 2007, see the notes in our financial
statements in our Annual Report on
Form 20-F
for the respective year. See the
Grants of Plan-Based
Awards Table
in this Proxy Statement for information
on share option awards granted in fiscal year 2007.
|
|
(4)
|
|
Represents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matching
|
|
Reimbursement
|
|
|
|
|
|
|
Contribution
|
|
for Long-Term
|
|
|
|
|
|
|
Under Our
|
|
Disability
|
|
|
|
|
|
|
401(k) Plan
|
|
Insurance
|
|
Other
|
|
Total
|
Name
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Peter M. Zotto
|
|
|
6,600
|
|
|
411
|
|
|
4,000
|
(a)
|
|
|
11,011
|
|
Robert C. McBride
|
|
|
6,600
|
|
|
411
|
|
|
|
|
|
|
7,011
|
|
William B. McMurray
|
|
|
6,600
|
|
|
411
|
|
|
32,836
|
(b)
|
|
|
39,847
|
|
Lawrence E. Alston, Jr.
|
|
|
6,600
|
|
|
411
|
|
|
|
|
|
|
7,011
|
|
Christopher M. Mirabile
|
|
|
6,600
|
|
|
411
|
|
|
|
|
|
|
7,011
|
|
28
|
|
|
(a)
|
|
Represents a payment to Mr. Zotto in lieu of his
participation in the Companys health, vision and dental
insurance plans.
|
|
(b)
|
|
Represents a payment to Mr. McMurray to cover income taxes
incurred by him in the United Kingdom in 2004.
|
|
|
|
(5)
|
|
Represents the aggregate payments made to Mr. McMurray
pursuant to his sales commission and MBO bonus programs
described above under the section titled
Variable Cash
Compensation
.
|
|
(6)
|
|
Represents a payment of $63,000 pursuant to
Mr. Alstons sales commission program described above
under the section titled
Variable Cash
Compensation
.
|
|
(7)
|
|
Represents a discretionary bonus awarded under the 2007 Senior
Management Team Bonus Program.
|
Grants of
Plan-Based Awards in 2007
The following table sets forth information about grants of
plan-based awards during the fiscal year ended December 31,
2007 to our Named Executive Officers.
GRANTS OF
PLAN-BASED AWARDS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All other
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All other
|
|
Option
|
|
|
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share
|
|
Awards:
|
|
Exercise
|
|
Closing
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Number of
|
|
or Base
|
|
Market
|
|
Value of
|
|
|
|
|
|
|
|
|
|
|
Estimated Future Payouts
|
|
Number of
|
|
Securities
|
|
Price of
|
|
Price on
|
|
Shares
|
|
|
|
|
Estimated Future Payouts Under Non-Equity Incentive Plan
Awards(2)
|
|
Under Equity Incentive Plan Awards(3)
|
|
Shares
|
|
Underlying
|
|
Option
|
|
Grant
|
|
and
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
or Units
|
|
Options(4)
|
|
Awards(5)
|
|
Date(5)
|
|
Option
|
Name
|
|
Date(1)
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
($/Sh)
|
|
($/Sh)
|
|
Awards(6)
|
|
Peter M. Zotto
|
|
|
|
|
|
|
62,500
|
|
|
|
250,000
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
5.33
|
|
|
|
5.35
|
|
|
|
216,000
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,450
|
|
|
|
41,500
|
|
|
|
49,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert C. McBride
|
|
|
|
|
|
|
25,000
|
|
|
|
100,000
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,900
|
|
|
|
33,000
|
|
|
|
39,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William B. McMurray
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210,000
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
5.33
|
|
|
|
5.35
|
|
|
|
86,400
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,950
|
|
|
|
16,500
|
|
|
|
19,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6/13/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
25,000
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence E. Alston, Jr.
|
|
|
|
|
|
|
10,500
|
|
|
|
42,000
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63,000
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
5.33
|
|
|
|
5.35
|
|
|
|
72,000
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,200
|
|
|
|
14,000
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher M. Mirabile
|
|
|
|
|
|
|
13,000
|
|
|
|
52,000
|
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
5.33
|
|
|
|
5.35
|
|
|
|
72,000
|
|
|
|
|
2/12/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,200
|
|
|
|
14,000
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The grant date refers to the date of grant for each equity-based
award reported in the table.
|
|
(2)
|
|
Our non-equity incentive plan consists of the 2007 Senior
Management Team Bonus Program. The actual amounts realized with
respect to the non-equity incentive plan awards are reported in
the
Summary Compensation Table
in this Proxy
Statement, under the Bonus and Non-Equity Incentive Plan
Compensation columns.
|
|
(3)
|
|
Represents phantom share units awarded under our 2006 Share
Incentive Plan. The numbers in the table above represent the
threshold, target and maximum number of shares that could have
vested over a three year period in accordance with the following
schedule if the target performance-based Company objectives for
the fiscal year ended December 31, 2007 had been achieved:
25% on January 1, 2008, 25% on January 1, 2009 and 50%
on January 1, 2010. None of the minimum performance-based
Company objectives were achieved and therefore all of the
phantom share units automatically expired on January 1,
2008. If the minimum performance-based objectives had been
achieved, then between 30% and 100% of each award would have
vested depending on the Companys total performance on a
sliding scale between certain minimum and target
performance-based objectives. If the target performance-based
objectives had been exceeded, then up to a maximum of 120% of
each award would have vested depending on the
|
29
|
|
|
|
|
Companys total performance on a sliding scale. See the
section titled
Equity Incentives
above for
more details about the phantom share units granted to our Named
Executive Officers.
|
|
(4)
|
|
All of the options in this column were granted under our
2006 Share Incentive Plan and vest over four years in
accordance with the following schedule, subject to our Named
Executive Officers continued employment: 25% vest on the
first anniversary of the grant date and 6.25% vest quarterly
thereafter.
|
|
(5)
|
|
Our Ordinary Shares are listed and traded on the Irish Stock
Exchange and also on the NASDAQ Global Market, in the form of
American Depositary Receipts. Because trading in our shares
occurs on two different exchanges in different time zones, the
Companys policy is to use the closing market price on the
date of the business day immediately preceding the grant date to
determine the exercise price for all option grants.
|
|
(6)
|
|
This column represents the fair value for financial statement
reporting purposes in accordance with FAS 123R for share
option awards granted to each of our Named Executive Officers in
fiscal year 2007, and does not reflect whether the recipient has
actually realized a financial benefit from the awards (such as
by exercising share options). Pursuant to SEC rules, the amounts
shown exclude the impact of estimated forfeitures related to
service-based vesting conditions. There can be no assurance that
the FAS 123R amount will ever be realized. For information
on the valuation assumptions underlying the grant date fair
value of these awards, see the notes to our financial statements
in our annual report on
Form 10-K
for the year ended December 31, 2007, as filed with the SEC.
|
|
(7)
|
|
The amounts shown in the threshold and target columns reflect
the minimum and target cash bonuses payable under the 2007
Senior Management Team Bonus Program. The Compensation Committee
has the discretion to award bonuses in excess of the target
amounts listed above if the target performance-based objectives
are exceeded.
|
|
(8)
|
|
The amounts shown in the threshold and target columns reflect
the minimum and target cash bonuses payable under the sales
commission programs established by our Compensation Committee
for Messrs. McMurray and Alston. The Compensation Committee
has the discretion to award bonuses in excess of the target
amounts listed above if the target performance-based objectives
are exceeded.
|
|
(9)
|
|
The amounts shown in the threshold and target columns reflect
the minimum and target cash bonuses payable under the MBO bonus
opportunity established for Mr. McMurray under the 2007
Senior Management Team Bonus Program. The Compensation Committee
has the discretion to award bonuses in excess of the target
amounts listed above if the target objectives are exceeded.
|
30
Outstanding
Equity Awards at December 31, 2007
The following table sets forth information regarding unexercised
and vested or unvested options that were held as of
December 31, 2007 for each of our Named Executive Officers.
The market and payout values for the phantom share units are
calculated based on a market value of $3.26 per share (the
closing price of the ADRs evidencing ADSs representing our
Ordinary Shares on the NASDAQ Global Market on December 31,
2007) multiplied by the number of shares that would have
vested if the target performance-based Company objectives for
the fiscal year ended December 31, 2007 had been achieved.
OUTSTANDING
EQUITY AWARDS AT DECEMBER 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards(1)
|
|
Share Awards(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Payout
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
Number of
|
|
|
Market
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
|
Shares or
|
|
|
Value of
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
Number of
|
|
|
Number of
|
|
|
of Securities
|
|
|
|
|
|
|
|
Units of
|
|
|
Shares
|
|
|
Units or
|
|
|
Units or
|
|
|
|
Securities
|
|
|
Securities
|
|
|
Underlying
|
|
|
|
|
|
|
|
Shares
|
|
|
or Units
|
|
|
Other
|
|
|
Other
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Option
|
|
|
Option
|
|
That Have
|
|
|
That
|
|
|
Rights
|
|
|
Rights That
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Unearned
|
|
|
Exercise
|
|
|
Expiration
|
|
Not
|
|
|
Have Not
|
|
|
That Have
|
|
|
Have Not
|
|
|
|
Options (#)
|
|
|
Options (#)
|
|
|
Options
|
|
|
Price
|
|
|
Date
|
|
Vested
|
|
|
Vested
|
|
|
Not Vested
|
|
|
Vested
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
(#)
|
|
|
($)
|
|
|
(2)
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Peter M. Zotto
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
|
|
10/13/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,875
|
|
|
|
13,125
|
|
|
|
|
|
|
|
3.26
|
|
|
8/17/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
171,875
|
|
|
|
78,125
|
|
|
|
|
|
|
|
5.30
|
|
|
2/1/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54,688
|
|
|
|
70,312
|
|
|
|
|
|
|
|
3.68
|
|
|
2/23/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
5.33
|
|
|
2/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,500
|
(4)
|
|
|
135,290
|
|
Robert C. McBride
|
|
|
131,250
|
|
|
|
168,750
|
|
|
|
|
|
|
|
3.75
|
|
|
2/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,000
|
(4)
|
|
|
107,580
|
|
William B. McMurray
|
|
|
112,500
|
|
|
|
37,500
|
|
|
|
|
|
|
|
5.47
|
|
|
1/8/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,313
|
|
|
|
4,688
|
|
|
|
|
|
|
|
3.26
|
|
|
8/17/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,375
|
|
|
|
15,625
|
|
|
|
|
|
|
|
5.30
|
|
|
2/1/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
25,000
|
|
|
|
|
|
|
|
2.85
|
|
|
10/21/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,125
|
|
|
|
46,875
|
|
|
|
|
|
|
|
4.30
|
|
|
5/9/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
5.33
|
|
|
2/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,500
|
(4)
|
|
|
53,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
(5)
|
|
|
81,500
|
|
Lawrence E. Alston, Jr.
|
|
|
87,500
|
|
|
|
12,500
|
|
|
|
|
|
|
|
5.29
|
|
|
5/24/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,688
|
|
|
|
4,687
|
|
|
|
|
|
|
|
3.26
|
|
|
8/17/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,376
|
|
|
|
15,624
|
|
|
|
|
|
|
|
5.30
|
|
|
2/1/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,250
|
|
|
|
30,000
|
|
|
|
|
|
|
|
2.85
|
|
|
10/21/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,375
|
|
|
|
40,625
|
|
|
|
|
|
|
|
4.30
|
|
|
5/9/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
5.33
|
|
|
2/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
(4)
|
|
|
45,640
|
|
Christopher M. Mirabile
|
|
|
17,101
|
|
|
|
|
|
|
|
|
|
|
|
1.99
|
|
|
5/15/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
2.20
|
|
|
8/1/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,000
|
|
|
|
|
|
|
|
|
|
|
|
2.68
|
|
|
9/3/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,125
|
|
|
|
1,875
|
|
|
|
|
|
|
|
7.33
|
|
|
2/10/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,312
|
|
|
|
4,688
|
|
|
|
|
|
|
|
3.26
|
|
|
8/17/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,188
|
|
|
|
7,812
|
|
|
|
|
|
|
|
5.30
|
|
|
2/1/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,500
|
|
|
|
12,500
|
|
|
|
|
|
|
|
2.85
|
|
|
10/21/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,750
|
|
|
|
31,250
|
|
|
|
|
|
|
|
4.30
|
|
|
5/9/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
5.33
|
|
|
2/12/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
(4)
|
|
|
45,640
|
|
31
|
|
|
(1)
|
|
All share options shown in this table vest over the first four
years of the ten year option term in accordance with the
following schedule, subject to our Named Executive
Officers continued employment: 25% vest on the first
anniversary of the grant date and 6.25% vest quarterly
thereafter.
|
|
(2)
|
|
The grant date of each option is ten years prior to its
expiration date.
|
|
(3)
|
|
The number of phantom share units listed in the table above
represents the target number of shares that could have vested
over a three year period in accordance with the following
schedule if the target performance-based Company objectives for
the fiscal year ended December 31, 2007 had been achieved:
25% on January 1, 2008, 25% on January 1, 2009 and 50%
on January 1, 2010. None of the minimum performance-based
Company objectives were achieved and therefore all of the
phantom share units automatically expired on January 1,
2008. If the minimum performance-based objectives had been
achieved, then between 30% and 100% of each award would have
vested depending on the Companys total performance on a
sliding scale between certain minimum and target
performance-based objectives. If the target performance-based
objectives had been exceeded, then up to a maximum of 120% of
each award would have vested depending on the Companys
total performance on a sliding scale. See the section titled
Equity Incentives
above for more details
about the phantom share units granted to our Named Executive
Officers.
|
|
(4)
|
|
The grant date of each phantom share unit award was
February 12, 2007.
|
|
(5)
|
|
The grant date of the phantom share unit award was June 13,
2007.
|
Option
Exercises and Shares Vested
The following table sets forth information with respect to the
exercise of share options during the fiscal year ended
December 31, 2007 for each of our Named Executive Officers.
OPTION
EXERCISES AND SHARES VESTED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Share Awards
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
|
|
on Exercise
|
|
|
on Exercise
|
|
|
on Vesting
|
|
|
on Vesting
|
|
Name
|
|
(#)
|
|
|
($)(1)
|
|
|
(#)
|
|
|
($)
|
|
|
Peter M. Zotto
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert C. McBride
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William B. McMurray
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence E. Alston, Jr.
|
|
|
34,375
|
|
|
|
99,732
|
|
|
|
|
|
|
|
|
|
Christopher M. Mirabile
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Represents the difference between the exercise price and the
fair market value of the Ordinary Shares on the date of exercise
for each option. Amounts are rounded to the nearest dollar.
|
Pension
Benefits
Other than participation in our 401(k) plan, IONA does not
provide pension benefits to our Named Executive Officers.
Nonqualified
Contribution and Other Nonqualified Deferred Compensation
Plans
IONA does not have any non-qualified deferred compensation plans.
Potential
Benefits Upon Termination of Employment or a Change in
Control
The following is a discussion of the compensation and benefits
due to each of our Named Executive Officers in the event of such
executive officers termination of employment or a
Change in Control of IONA. Amounts and benefits
discussed below relating to Peter M. Zottos employment
agreement are based on his employment contract in effect on
December 31, 2007. Effective April 14, 2008,
Mr. Zottos new
32
employment contract will provide him with an annual base salary
of $400,000, an annual bonus of up to $300,000 and a lump sum
payment of $5,000 per year for health, dental and life
insurance. Further, Mr. Zotto will be eligible to receive
up to $7,000 for annual life insurance policy premiums and, upon
the occurrence of certain terminations, Mr. Zotto will also
be eligible to receive health, vision and dental insurance
benefits for Mr. Zotto and his dependents for up to
18 months following such termination or, if such coverage
is unavailable, a lump sum payment of $7,500. The remaining
terms of Mr. Zottos new employment contract are
substantially the same as those of his previous employment
agreement.
Payments
and Benefits upon any Termination of Employment
Our employees, including our Named Executive Officers, are
entitled to receive earned but unpaid compensation upon any
termination of employment. Accordingly, subject to the
exceptions noted below, upon any termination of employment, our
Named Executive Officers will receive accrued but unused
vacation pay and earned but unpaid bonuses up to the date of
termination. The payments due upon any termination of employment
will generally be made in a lump sum payment within two weeks
after termination of employment or in accordance with our normal
payroll practices, whichever is earlier. In addition, except as
noted below, all unvested share awards and share options held by
our Named Executive Officers will expire upon termination of
employment and all vested share options expire 30 days
after termination of employment or upon their expiration date,
whichever is earlier.
Voluntary
Termination of Employment
Our Named Executive Officers who voluntarily terminate their
employment with IONA, other than in connection with a
Change in Control of IONA, are not entitled to any
compensation, benefits or other rights other than those that are
paid or granted to all employees upon any termination of
employment as described in the section above titled
Payments and Benefits upon any Termination of
Employment
.
Peter M.
Zotto Employment Agreement
Mr. Zotto is required under his employment agreement to
provide IONA with (i) at least six months written notice of
his intent to terminate his employment at the end of the initial
term and (ii) at least three months written notice of his
intent to terminate his employment at the end of any extension
period. If Mr. Zotto provides such notice, the Company may
elect to waive the notice period and accelerate the termination
date without any obligation to pay Mr. Zotto severance
during the remainder of the notice period. In such an instance,
Mr. Zotto would be entitled to receive the compensation,
benefits described in the section above titled
Payments
and Benefits upon any Termination of Employment.
In addition to the foregoing benefits, upon a voluntary
termination of employment by Mr. Zotto for Good
Reason, other than because of a Change in
Control of IONA, he is entitled to receive:
|
|
|
|
|
a lump sum severance payment equal to 18 months of his then
current annual base salary plus up to 150% of his target bonus
for the year of termination;
|
|
|
|
health, vision and dental insurance benefits for Mr. Zotto
and his dependents for up to 18 months following such
termination or, if such coverage is unavailable, a lump sum
payment of $6,000; and
|
|
|
|
all of the equity awards that would have vested within
18 months after the date of termination shall immediately
vest and remain exercisable for three months (or in the event of
Mr. Zottos death during such three-month period, for
one year) or until their expiration, whichever is earlier.
|
Involuntary
Termination of Employment other than for
Cause
Except in connection with a Change in Control of
IONA, upon an involuntary termination of employment other than
for cause, our Named Executive Officers are not
contractually entitled to any compensation, benefits or other
rights other than those that are paid or granted to all
employees upon any termination of employment as described in the
section above titled
Payments and Benefits upon any
Termination of Employment.
33
Peter M.
Zotto Employment Agreement
In addition to the foregoing benefits, upon an involuntary
termination other than for Cause, other than because
of a Change in Control of IONA, Mr. Zotto is
entitled to receive:
|
|
|
|
|
a lump sum severance payment equal to 18 months of his then
current annual base salary plus up to 150% of his target bonus
for the year of termination;
|
|
|
|
health, vision and dental insurance benefits for Mr. Zotto
and his dependents for up to 18 months following such
termination or, if such coverage is unavailable, a lump sum
payment of $6,000; and
|
|
|
|
all of the equity awards that would have vested within
18 months after the date of termination shall immediately
vest and remain exercisable for three months (or in the event of
Mr. Zottos death during such three-month period, for
one year) or until their expiration, whichever is earlier.
|
Involuntary
Termination of Employment for Cause
Upon an involuntary termination of employment for
cause, our Named Executive Officers will receive
earned but unpaid compensation, accrued but unused vacation pay
and earned but unpaid bonuses up to the date of termination. The
payments due upon any termination of employment will generally
be made in a lump sum payment within two weeks after termination
of employment or in accordance with our normal payroll
practices, whichever is earlier. In addition, all outstanding
equity awards automatically terminate as of the date of
termination.
Termination
of Employment Due to Disability
In addition to providing the benefits that are provided to all
employees generally upon any termination of employment as
described in the section above titled
Payments and
Benefits upon any Termination of Employment,
upon the
permanent disability of an employee, all outstanding vested
equity awards shall remain exercisable for 12 months or
until their expiration, whichever is earlier.
Termination
of Employment Due to Death
In addition to providing the benefits that are provided to all
employees generally upon any termination of employment as
described in the section above titled
Payments and
Benefits upon any Termination of Employment,
upon the
death of an employee, all outstanding share options shall
immediately vest and remain exercisable for 12 months or
until their expiration, whichever is earlier. In addition, all
phantom share units held by our Named Executive Officers which
have partially vested as a result of satisfaction of the
performance-based objectives (but have not satisfied the
time-vesting component), shall immediately vest.
Termination
of Employment in Connection with a Change in Control
of IONA
We have Change in Control agreements with all of our
executive officers, including our Named Executive Officers, that
provide the following benefits if (i) there is a
Change in Control of IONA and (ii) the
executive officers employment is (A) involuntarily
terminated by IONA (or any successor) without Cause
within two years following a Change in Control or
during the three month period immediately preceding the
Change in Control or (B) voluntarily terminated
by the executive officer for Good Reason within two
years following a Change in Control:
|
|
|
|
|
a lump sum severance payment equal to two times the sum of his
base salary (using the highest base salary between the date of
the Change in Control event and the termination
date) and target annual bonus (using the highest target bonus
amount that the executive was eligibility to receive with
respect to any one calendar year in the period beginning in the
calendar year prior to that in which the Change in
Control occurs and ending in the calendar year in which
the executives employment was terminated) for the year of
termination assuming maximum performance;
|
|
|
|
the continuation of health insurance benefits for himself and
his dependents for up to two years following such
termination; and
|
|
|
|
all of his equity awards, assuming maximum performance, shall
immediately vest and remain exercisable, generally, for three
months after the date of termination or until their expiration,
whichever is earlier.
|
34
In each case, the receipt of any Change in Control
benefits is conditioned on the executive officer, including a
Named Executive Officer, executing a separation agreement and
continuing to comply in all material respects with any
non-competition, invention
and/or
non-disclosure obligations he may have to the Company. If the
Named Executive Officer fails to continue to comply with any of
these obligations, he will cease to receive any cash benefits,
will be required to repay to the Company any cash benefits
already received, and all options, awards and purchase rights
held by him will no longer be exercisable as of the date of the
breach.
Change
in Control of IONA
Under our Change in Control agreements with all of
our executive officers, including our Named Executive Officers,
if a Change in Control of IONA occurs and the
successor entity does not, as of the effective date of such
Change in Control, (a) adopt and assume the
Stock Plans that are in effect immediately prior to
such Change in Control or (b) substitute, on an
equitable basis, such successors securities, having terms
and conditions no less favorable to the executive officer than
the terms and conditions of the then outstanding securities
under the Stock Plans, for the then outstanding
stock, options, awards and purchase rights under the Stock
Plans, then all unvested stock, options, awards and
purchase rights granted to each executive officer under any of
the Stock Plans prior to such Change in
Control shall immediately become fully vested and
exercisable as of the effective date of the Change in
Control.
Payments
Upon Termination of Employment or a Change in
Control of IONA
Peter M.
Zotto
The following table shows the potential payments and benefits
that Mr. Zotto would be entitled to as of December 31,
2007, if (i) his employment is involuntarily terminated by
IONA for Cause; (ii) his employment is
involuntarily terminated by IONA other than for
Cause or he voluntarily terminates his employment
for Good Reason, other than in connection with a
Change in Control; (iii) his employment is
terminated as a result of his becoming permanently disabled or
he voluntarily terminates his employment other than for
Good Reason; (iv) his employment is terminated
as a result of his death; (v) (A) there is a Change
in Control of IONA and (B) his employment is
involuntarily terminated by IONA (or any successor) without
Cause or he voluntarily terminates his employment
for Good Reason; or (vi) there is a
Change in Control of IONA. The amounts shown in the
table below assume that each termination of employment was
effective as of December 31, 2007 and that the fair market
value of our Ordinary Shares was $3.26, the closing price of the
ADRs evidencing ADSs representing our Ordinary Shares on the
NASDAQ Global Market on that date. The amounts shown in the
table below do not include amounts payable for accrued vacation.
The amounts shown in the table are estimates of the amounts
which would be paid upon termination of employment. The actual
amounts to be paid can only be determined at the time of the
termination of employment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Termination for
|
|
|
|
|
|
Other than for
|
|
|
|
|
|
|
|
|
|
Other than for
|
|
|
Disability or
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
Cause or
|
|
|
Voluntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
Involuntary
|
|
|
Voluntary
|
|
|
Termination
|
|
|
|
|
|
Termination for
|
|
|
|
|
|
|
Termination for
|
|
|
Termination for
|
|
|
Other than for
|
|
|
Termination
|
|
|
Good Reason
|
|
|
|
|
|
|
Cause
|
|
|
Good Reason
|
|
|
Good Reason
|
|
|
Upon Death
|
|
|
Upon a Change
|
|
|
Change in
|
|
Payments and Benefits
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
in Control
|
|
|
Control
|
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base Salary
|
|
|
|
|
|
|
562,500
|
|
|
|
|
|
|
|
|
|
|
|
750,000
|
|
|
|
|
|
Target Bonus
|
|
|
|
|
|
|
375,000
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
Health Insurance Continuation
|
|
|
|
|
|
|
6,000
|
(1)
|
|
|
|
|
|
|
|
|
|
|
8,000
|
(1)
|
|
|
|
|
Equity Awards(2)
|
|
|
|
|
|
|
78,000
|
|
|
|
78,000
|
|
|
|
78,000
|
|
|
|
78,000
|
|
|
|
78,000
|
|
Total
|
|
|
|
|
|
|
1,021,500
|
|
|
|
78,000
|
|
|
|
78,000
|
|
|
|
1,336,000
|
|
|
|
78,000
|
|
35
|
|
|
(1)
|
|
Represents the payment by the Company of a lump sum payment in
lieu of the continuation of health, vision and dental insurance.
|
|
(2)
|
|
Represents the intrinsic value (that is, the value based upon
our share price on December 31, 2007 minus the exercise
price) and assumes (i) that all underwater
share options (that is, share options with an exercise price
greater than our share price on December 31,
2007) would not be exercised and (ii) that all of the
phantom share units did not vest.
|
Robert C.
McBride
The following table shows the potential payments and benefits
that Mr. McBride would be entitled to as of
December 31, 2007, if (i) his employment is
involuntarily terminated by IONA for Cause;
(ii) his employment is involuntarily terminated by IONA
other than for Cause or he voluntarily terminates
his employment for Good Reason, other than in
connection with a Change in Control; (iii) his
employment is terminated as a result of his becoming permanently
disabled or he voluntarily terminates his employment other than
for Good Reason; (iv) his employment is
terminated as a result of his death; (v) (A) there is a
Change in Control of IONA and (B) his
employment is involuntarily terminated by IONA (or any
successor) without Cause or he voluntarily
terminates his employment for Good Reason; or
(vi) there is a Change in Control of IONA. The
amounts shown in the table below assume that each termination of
employment was effective as of December 31, 2007 and that
the fair market value of our Ordinary Shares was $3.26, the
closing price of the ADRs evidencing ADSs representing our
Ordinary Shares on the NASDAQ Global Market on that date. The
amounts shown in the table below do not include amounts payable
for accrued vacation. The amounts shown in the table are
estimates of the amounts which would be paid upon termination of
employment. The actual amounts to be paid can only be determined
at the time of the termination of employment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
Termination
|
|
Termination for
|
|
|
|
Other than for
|
|
|
|
|
|
|
Other than for
|
|
Disability or
|
|
|
|
Cause or
|
|
|
|
|
|
|
Cause or
|
|
Voluntary
|
|
|
|
Voluntary
|
|
|
|
|
Involuntary
|
|
Voluntary
|
|
Termination
|
|
|
|
Termination for
|
|
|
|
|
Termination for
|
|
Termination for
|
|
other than for
|
|
Termination
|
|
Good Reason
|
|
|
|
|
Cause
|
|
Good Reason
|
|
Good Reason
|
|
Upon Death
|
|
Upon a Change
|
|
Change in
|
Payments and Benefits
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
in Control
|
|
Control
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base Salary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
Target Bonus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
Health Insurance Continuation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,516
|
|
|
|
|
|
Equity Awards(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
723,516
|
|
|
|
|
|
|
|
|
(1)
|
|
Represents the intrinsic value (that is, the value based upon
our share price on December 31, 2007 minus the exercise
price) and assumes (i) that all underwater
share options (that is, share options with an exercise price
greater than our share price on December 31,
2007) would not be exercised and (ii) that all of the
phantom share units did not vest.
|
36
William
B. McMurray
The following table shows the potential payments and benefits
that Mr. McMurray would be entitled to as of
December 31, 2007, if (i) his employment is
involuntarily terminated by IONA for Cause;
(ii) his employment is involuntarily terminated by IONA
other than for Cause or he voluntarily terminates
his employment for Good Reason, other than in
connection with a Change in Control; (iii) his
employment is terminated as a result of his becoming permanently
disabled or he voluntarily terminates his employment other than
for Good Reason; (iv) his employment is
terminated as a result of his death; (v) (A) there is a
Change in Control of IONA and (B) his
employment is involuntarily terminated by IONA (or any
successor) without Cause or he voluntarily
terminates his employment for Good Reason; or
(vi) there is a Change in Control of IONA. The
amounts shown in the table below assume that each termination of
employment was effective as of December 31, 2007 and that
the fair market value of our Ordinary Shares was $3.26, the
closing price of the ADRs evidencing ADSs representing our
Ordinary Shares on the NASDAQ Global Market on that date. The
amounts shown in the table below do not include amounts payable
for accrued vacation. The amounts shown in the table are
estimates of the amounts which would be paid upon termination of
employment. The actual amounts to be paid can only be determined
at the time of the termination of employment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Termination for
|
|
|
|
|
|
Other than for
|
|
|
|
|
|
|
|
|
|
Other than for
|
|
|
Disability or
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
Cause or
|
|
|
Voluntary
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
|
Involuntary
|
|
|
Voluntary
|
|
|
Termination Other
|
|
|
|
|
|
Termination for
|
|
|
|
|
|
|
Termination for
|
|
|
Termination for
|
|
|
than for
|
|
|
Termination
|
|
|
Good Reason
|
|
|
|
|
|
|
Cause
|
|
|
Good Reason
|
|
|
Good Reason
|
|
|
Upon Death
|
|
|
Upon a Change
|
|
|
Change in
|
|
Payments and Benefits
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
in Control
|
|
|
Control
|
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base Salary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600,000
|
|
|
|
|
|
Target Bonus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
Health Insurance Continuation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,274
|
|
|
|
|
|
Equity Awards(1)
|
|
|
|
|
|
|
|
|
|
|
10,250
|
|
|
|
10,250
|
|
|
|
20,500
|
|
|
|
20,500
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
10,250
|
|
|
|
10,250
|
|
|
|
1,155,774
|
|
|
|
20,500
|
|
|
|
|
(1)
|
|
Represents the intrinsic value (that is, the value based upon
our share price on December 31, 2007 minus the exercise
price) and assumes (i) that all underwater
share options (that is, share options with an exercise price
greater than our share price on December 31,
2007) would not be exercised and (ii) that all of the
phantom share units did not vest.
|
Lawrence
E. Alston,
Jr.
The following table shows the potential payments and benefits
that Mr. Alston would be entitled to as of
December 31, 2007, if (i) his employment is
involuntarily terminated by IONA for Cause;
(ii) his employment is involuntarily terminated by IONA
other than for Cause or he voluntarily terminates
his employment for Good Reason, other than in
connection with a Change in Control; (iii) his
employment is terminated as a result of his becoming permanently
disabled or he voluntarily terminates his employment other than
for Good Reason; (iv) his employment is
terminated as a result of his death; (v) (A) there is a
Change in Control of IONA and (B) his
employment is involuntarily terminated by IONA (or any
successor) without Cause or he voluntarily
terminates his employment for Good Reason; or
(vi) there is a Change in Control of IONA. The
amounts shown in the table below assume that each termination of
employment was effective as of December 31, 2007 and that
the fair market value of our Ordinary Shares was $3.26, the
closing price of the ADRs evidencing ADSs representing our
Ordinary Shares on the NASDAQ Global Market on that date. The
amounts shown in the table below do not include amounts payable
for accrued vacation. The amounts shown in the table are
estimates
37
of the amounts which would be paid upon termination of
employment. The actual amounts to be paid can only be determined
at the time of the termination of employment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
Termination
|
|
Termination for
|
|
|
|
Other than for
|
|
|
|
|
|
|
Other than for
|
|
Disability or
|
|
|
|
Cause or
|
|
|
|
|
|
|
Cause or
|
|
Voluntary
|
|
|
|
Voluntary
|
|
|
|
|
Involuntary
|
|
Voluntary
|
|
Termination Other
|
|
|
|
Termination for
|
|
|
|
|
Termination for
|
|
Termination for
|
|
than for
|
|
Termination
|
|
Good Reason
|
|
|
|
|
Cause
|
|
Good Reason
|
|
Good Reason
|
|
Upon Death
|
|
Upon a Change
|
|
Change in
|
Payments and Benefits
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
in Control
|
|
Control
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base Salary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
504,000
|
|
|
|
|
|
Target Bonus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210,000
|
|
|
|
|
|
Health Insurance Continuation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,274
|
|
|
|
|
|
Equity Awards(1)
|
|
|
|
|
|
|
|
|
|
|
4,613
|
|
|
|
16,913
|
|
|
|
16,913
|
|
|
|
16,913
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
4,613
|
|
|
|
16,913
|
|
|
|
766,187
|
|
|
|
16,913
|
|
|
|
|
(1)
|
|
Represents the intrinsic value (that is, the value based upon
our share price on December 31, 2007 minus the exercise
price) and assumes (i) that all underwater
share options (that is, share options with an exercise price
greater than our share price on December 31,
2007) would not be exercised and (ii) that all of the
phantom share units did not vest.
|
Christopher
M. Mirabile
The following table shows the potential payments and benefits
that Mr. Mirabile would be entitled to as of
December 31, 2007, if (i) his employment is
involuntarily terminated by IONA for Cause;
(ii) his employment is involuntarily terminated by IONA
other than for Cause or he voluntarily terminates
his employment for Good Reason, other than in
connection with a Change in Control; (iii) his
employment is terminated as a result of his becoming permanently
disabled or he voluntarily terminates his employment other than
for Good Reason; (iv) his employment is
terminated as a result of his death; (v) (A) there is a
Change in Control of IONA and (B) his
employment is involuntarily terminated by IONA (or any
successor) without Cause or he voluntarily
terminates his employment for Good Reason; or
(vi) there is a Change in Control of IONA. The
amounts shown in the table below assume that each termination of
employment was effective as of December 31, 2007 and that
the fair market value of our Ordinary Shares was $3.26, the
closing price of the ADRs evidencing ADSs representing our
Ordinary Shares on the NASDAQ Global Market on that date. The
amounts shown in the table below do not include amounts payable
for accrued vacation. The amounts shown in the table are
estimates of the amounts which would be paid upon termination of
employment. The actual amounts to be paid can only be determined
at the time of the termination of employment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
Termination
|
|
Termination for
|
|
|
|
Termination Other
|
|
|
|
|
|
|
Other than for
|
|
Disability or
|
|
|
|
than for Cause
|
|
|
|
|
|
|
Cause or
|
|
Voluntary
|
|
|
|
or Voluntary
|
|
|
|
|
Involuntary
|
|
Voluntary
|
|
Termination
|
|
|
|
Termination for
|
|
|
|
|
Termination for
|
|
Termination for
|
|
Other than for
|
|
Termination
|
|
Good Reason
|
|
|
|
|
Cause
|
|
Good Reason
|
|
Good Reason
|
|
Upon Death
|
|
Upon a Change
|
|
Change in
|
Payments and Benefits
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
in Control
|
|
Control
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base Salary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
520,000
|
|
|
|
|
|
Target Bonus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
|
|
|
Health Insurance Continuation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,274
|
|
|
|
|
|
Equity Awards(1)
|
|
|
|
|
|
|
|
|
|
|
57,743
|
|
|
|
62,868
|
|
|
|
62,868
|
|
|
|
62,868
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
57,743
|
|
|
|
62,868
|
|
|
|
768,142
|
|
|
|
62,868
|
|
38
|
|
|
(1)
|
|
Represents the intrinsic value (that is, the value based upon
our share price on December 31, 2007 minus the exercise
price) and assumes (i) that all underwater
share options (that is, share options with an exercise price
greater than our share price on December 31,
2007) would not be exercised and (ii) that all of the
phantom share units did not vest.
|
Compensation
of Non-Executive Directors
The following table sets forth the monthly and per-meeting fees
paid during the fiscal year ended December 31, 2007 to each
non-executive director and our non-executive Chairman of the
Board, in each case subject to the annual per person maximums
also set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual per Person
|
|
|
Monthly Fee
|
|
Board Meeting Fee
|
|
Maximum
|
Non -Executive Director/Chairman
|
|
($)
|
|
($)
|
|
($)
|
|
Chairman
|
|
|
3,000
|
|
|
|
3,000
|
|
|
|
72,000
|
|
Member
|
|
|
3,000
|
|
|
|
1,500
|
|
|
|
48,000
|
|
The following table sets forth the per-meeting fees paid during
the fiscal year ended December 31, 2007 to each
non-executive member of the Audit Committee, Compensation
Committee, Nominating and Corporate Governance Committee and New
Markets Committee, and each non-executive chairman thereof,
during the fiscal year ended December 31, 2007 in each case
subject to the annual per person maximums also set forth below.
|
|
|
|
|
|
|
|
|
|
|
Compensation
|
|
|
|
Nominating and
|
|
New Markets
|
|
|
Committee
|
|
Audit Committee
|
|
Corporate Governance
|
|
Committee
|
|
|
Meeting Fee
|
|
Meeting Fee
|
|
Committee Meeting Fee
|
|
Meeting Fee
|
Committee Chairman/Member
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Chairman
|
|
3,000 (annual
|
|
3,000 (annual
|
|
3,000 (annual
|
|
3,000 (annual
|
|
|
maximum of 12,000)
|
|
maximum 24,000)
|
|
maximum of 12,000)
|
|
maximum 24,000)
|
Member
|
|
1,500 (annual
|
|
1,500 (annual
|
|
1,500 (annual
|
|
1,500 (annual
|
|
|
maximum of 6,000)
|
|
maximum of 12,000)
|
|
maximum of 6,000)
|
|
maximum of 12,000)
|
In addition, all directors were reimbursed for reasonable
out-of-pocket travel expenses incurred by them in attending
meetings of the Board of Directors, including committee meetings.
Under our 2006 Share Incentive Plan, each non-executive
director who is first elected to serve as a director will be
automatically granted non-qualified share options to acquire
30,000 Ordinary Shares on the date of his or her election.
Annually thereafter, but subject to availability under the
2006 Share Incentive Plan, each non-executive director who
is serving as a director of the Company immediately after each
annual general meeting will automatically receive either
(i) a non-qualified share option to acquire 3,000 Ordinary
Shares or (ii) in the event that the director is required
to seek re-election at such meeting, a non-qualified share
option to acquire 21,000 shares. However, if the
non-executive director has participated in fewer than 75% of the
meetings of the Board of Directors since the date of the last
annual general meeting, then no award or grant of any share
options will be made to such director. Unless otherwise
determined by the Compensation Committee, share option grants to
non-executive directors shall vest in accordance with the
following schedule: (a) one-third of the options will be
immediately vested as of the date of grant, (b) one-third
of the share options shall vest on the first anniversary of the
date of grant, and (c) the remaining one-third of the share
options will vest on the second anniversary of the date of grant.
Under our Non-Executive Directors Change in Control Plan, in the
event of a Change in Control of IONA, each
non-executive director shall receive the following (such amounts
are subject to reduction in the event that they constitute an
excessive parachute payment within the meaning of
Section 280G(b) of the Internal Revenue Code):
|
|
|
|
|
a lump sum payment equal to two times the maximum aggregate fees
that such Non-Executive Director is eligible to receive with
respect to services rendered in his capacity as a member of the
Board of Directors or any committee thereof either in the
calendar year in which the Change in Control occurs
or the calendar year prior thereto, whichever aggregate amount
is higher; and
|
39
|
|
|
|
|
all of his equity awards, assuming maximum performance of any
performance-based vesting requirements, shall immediately vest
on the date of the Change in Control and remain
exercisable, in accordance with the terms of the plan or scheme
under which they were granted.
|
The following table sets forth a summary of the compensation
earned by our non-executive directors for the fiscal year ended
December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All other
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Share
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
Awards ($)
|
|
|
($)(9)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Sean Baker
|
|
|
92,957
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,303
|
|
|
|
|
|
|
|
101,260
|
|
John Conroy
|
|
|
4,500
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,500
|
|
Christopher J. Horn
|
|
|
90,000
|
(3)
|
|
|
|
|
|
|
19,803
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109,803
|
|
Ivor Kenny
|
|
|
66,000
|
(4)
|
|
|
|
|
|
|
19,374
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85,374
|
|
James D. Maikranz
|
|
|
66,000
|
(5)
|
|
|
|
|
|
|
13,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79,022
|
|
Kevin C. Melia
|
|
|
174,000
|
(6)
|
|
|
|
|
|
|
40,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
214,237
|
|
Bruce J. Ryan
|
|
|
72,000
|
(7)
|
|
|
|
|
|
|
25,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97,487
|
|
Francesco Violante
|
|
|
55,500
|
(8)
|
|
|
|
|
|
|
19,374
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
74,874
|
|
|
|
|
(1)
|
|
Includes compensation paid to Mr. Baker in the amount of
$83,027 for serving as our Chief Corporate Scientist and fees in
the amount of $9,930 in directors fees.
|
|
(2)
|
|
Mr. Conroy retired from the Board of Directors on
January 25, 2007.
|
|
(3)
|
|
Includes compensation paid to Mr. Horn in the amount of
$42,000 for his services as Vice Chairman of the Board of
Directors.
|
|
(4)
|
|
Includes fees in the amount of (a) $12,000 for serving as
the chairman of the Compensation Committee and (b) $6,000
for serving as a member of the Nominating Committee.
|
|
(5)
|
|
Includes fees in the amount of (a) $7,500 for serving as a
member of the Audit Committee, (b) $6,000 for serving as a
member of the Compensation Committee and (c) $6,000 for
serving as the chairman of the New Markets Committee.
|
|
(6)
|
|
Includes compensation paid to Mr. Melia in the amount of
$84,000 for serving as our Chairman of the Board and fees in the
amount of (a) $12,000 for serving as a member of the Audit
Committee and (b) $12,000 for serving the chairman of the
Nominating Committee.
|
|
(7)
|
|
Includes fees in the amount of (a) $21,000 for serving as
the chairman of the Audit Committee and (b) $6,000 for
serving as a member of the Nominating Committee.
|
|
(8)
|
|
Includes fees in the amount of (a) $6,000 for serving as a
member of the Compensation Committee and (b) $3,000 for
serving as a member of the New Markets Committee.
|
|
(9)
|
|
This column represents the dollar amount recognized for
financial statement reporting purposes in accordance with
FAS 123R for fiscal year 2007 for share option awards
granted to each of our non-executive directors in fiscal year
2007 as well as in prior fiscal years, and does not reflect
whether the recipient has actually realized a financial benefit
from the awards (such as by exercising share options). Pursuant
to SEC rules, the amounts shown exclude the impact of estimated
forfeitures related to service-based vesting conditions. There
can be no assurance that the FAS 123R amount will ever be
realized. For additional information, see the notes to our
financial statements in our Annual Report on
Form 10-K
for the year ended December 31, 2007, as filed with the
SEC. For information on the valuation assumptions for grants
made prior to fiscal year 2007, see the notes in our financial
statements in our Annual Report on
Form 20-F
for the respective year. See the
Grants of Plan-Based
Awards Table
in this Proxy Statement for information
on share option awards granted in fiscal year 2007.
|
40
REPORT OF
THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS
No portion of this Report of the Compensation Committee shall
be deemed to be incorporated by reference into any filing under
the Securities Act or the Exchange Act through any general
statement incorporating by reference in its entirety the Proxy
Statement in which this report appears, except to the extent
that the Company specifically incorporates this report or a
portion of it by reference. In addition, this report shall not
be deemed filed under either the Securities Act or the Exchange
Act.
This report is submitted by the Compensation Committee of the
Board of Directors. The Compensation Committee currently
consists of Dr. Kenny (chairman) and Messrs. Maikranz
and Violante. The Compensation Committee of the Board of
Directors, which is comprised solely of independent directors
within the meaning of director independence standards of NASDAQ
and applicable rules of the SEC, outside directors within the
meaning of Section 162(m) of the Internal Revenue Code and
non-employee directors within the meaning of
Rule 16b-3
under the Exchange Act.
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis (the CD&A)
for the year ended December 31, 2007, which is contained in
this Proxy Statement, with the Companys management. In
reliance on the reviews and discussions referred to above, the
Compensation Committee recommended to the Board of Directors,
and the Board of Directors has approved, that the CD&A be
included in this Proxy Statement for the year ended
December 31, 2007 for filing with the SEC.
Respectfully submitted by the Compensation Committee,
Dr. Ivor Kenny,
Chairman
James D. Maikranz
Francesco Violante
41
SECURITY
OWNERSHIP OF CERTAIN BENEFICAL OWNERS AND MANAGEMENT
The following table sets forth information about the beneficial
ownership of Ordinary Shares owned as of March 31, 2008 by
(i) each person who is known by us to beneficially own more
than 5% of our Ordinary Shares, (ii) each member of our
Board of Directors, (iii) each of our Named Executive
Officers, and (iv) all directors and executive officers of
IONA as a group.
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of
|
|
|
Number of Shares
|
|
Outstanding
|
Name and Address of Beneficial Owner(1)
|
|
Beneficially Owned(2)
|
|
Shares
|
|
Peninsula Capital Management, LP
|
|
|
6,052,911
|
(3)
|
|
|
16.58
|
%
|
235 Pine Street, Suite 1600
San Francisco, California 94104
|
|
|
|
|
|
|
|
|
Lawrence E. Alston, Jr.
|
|
|
207,500
|
(4)
|
|
|
*
|
|
Seán Baker
|
|
|
1,248,398
|
(5)
|
|
|
3.42
|
%
|
Christopher J. Horn
|
|
|
2,356,614
|
(6)
|
|
|
6.45
|
%
|
Ivor Kenny
|
|
|
98,134
|
(7)
|
|
|
*
|
|
James D. Maikranz
|
|
|
63,750
|
(8)
|
|
|
*
|
|
Robert C. McBride
|
|
|
11,000
|
(9)
|
|
|
*
|
|
William B. McMurray
|
|
|
8,000
|
|
|
|
*
|
|
Kevin C. Melia
|
|
|
272,294
|
(10)
|
|
|
*
|
|
Christopher M. Mirabile
|
|
|
185,989
|
(11)
|
|
|
*
|
|
Bruce J. Ryan
|
|
|
21,000
|
(12)
|
|
|
*
|
|
Francesco Violante
|
|
|
70,300
|
(13)
|
|
|
*
|
|
Peter M. Zotto
|
|
|
698,500
|
(14)
|
|
|
1.91
|
%
|
All executive officers, directors and nominees as a group
(12 persons)
|
|
|
5,673,920
|
(15)
|
|
|
15.54
|
%
|
|
|
|
*
|
|
Represents less than 1%
|
|
(1)
|
|
Except as otherwise noted, (a) the address of each person
listed in the table above is
c/o IONA
Technologies PLC, The IONA Building, Shelbourne Road,
Ballsbridge, Dublin 4, Ireland and (b) all persons have
sole voting and investment power with respect to their shares.
|
|
(2)
|
|
All amounts shown in this column include shares obtainable upon
exercise of share options currently exercisable or exercisable
withint 60 days of the date of this table.
|
|
(3)
|
|
Based solely on the Form 4 filed by Peninsula Capital
Management, LP with the SEC on February 13, 2008. Such
Form 4 provides that the 6,052,911 shares are held in
the accounts of investment funds over which Peninsula Capital
Management, LP and Scott Bedford have shared investment
discretion and shared power to vote. Peninsula Capital
Management, LP is the general partner and/or the investment
manager of such investment funds and Scott Bedford is the
President of Peninsula Capital Management, Inc. which is
Peninsula Capital Management, LPs general partner.
|
|
(4)
|
|
Mr. Alston is deemed to own all of these shares by virtue
of options to purchase these shares.
|
|
(5)
|
|
Mr. Baker is deemed to own 77,513 of these shares by virtue
of options to purchase these shares.
|
|
(6)
|
|
Dr. Horn is deemed to own 18,200 of these shares by virtue
of options to purchase these shares.
|
|
(7)
|
|
Mr. Kenny is deemed to own 86,334 of these shares by virtue
of options to purchase these shares.
|
|
(8)
|
|
Mr. Maikranz is deemed to own 63,000 of these shares by
virtue of options to purchase these shares.
|
|
(9)
|
|
Based on the Form 3 filed by Mr. McBride with the SEC
on January 9, 2008, which provides that Mr. McBride
owns 11,000 Ordinary Shares.
|
|
(10)
|
|
Mr. Melia is deemed to own 226,250 of these shares by
virtue of options to purchase these shares. Excludes
575 shares owned by his son as to which Mr. Melia
disclaims beneficial ownership.
|
|
(11)
|
|
Mr. Mirabile is deemed to own 184,289 of these shares by
virtue of options to purchase these shares.
|
|
(12)
|
|
Mr. Ryan is deemed to own all of these shares by virtue of
options to purchase these shares.
|
|
(13)
|
|
Mr. Violante is deemed to own 69,000 of these shares by
virtue of options to purchase these shares.
|
|
(14)
|
|
Mr. Zotto is deemed to own 662,500 of these shares by
virtue of options to purchase these shares.
|
42
|
|
|
(15)
|
|
Includes 2,050,356 Ordinary Shares beneficially owned by all of
our executive officers and directors as a group by virtue of
options to purchase these shares. Excludes (i) shares as to
which such individuals have disclaimed beneficial ownership and
(ii) shares owned by Mr. McBride and
Mr. McMurray, both of whom are no longer with the Company.
|
SHAREHOLDER
PROPOSALS FOR IONAS 2009 ANNUAL GENERAL
MEETING
Shareholder
Proposals Relating to Director Nominations
To be eligible for inclusion in our proxy statement for the 2009
annual general meeting, shareholder proposals relating to the
nomination of a director candidate must be received by the
Secretary of the Company no later than April 10, 2009.
Shareholders that would like to submit a recommendation for a
director candidate without having such nomination be reviewed by
the Nominating and Corporate Governance Committee or included in
our proxy statement for the 2009 annual general meeting must
submit their recommendation for receipt by the Secretary of the
Company not later than the close of business on the
7
th
day
prior to the date selected for the 2009 annual general meeting
nor earlier than the 42nd day prior to the 2009 annual
general meeting.
All Other
Shareholder Proposals
To be eligible for inclusion in our proxy statement for the 2009
annual General Meeting, all other shareholder proposals must be
received by the Secretary of the Company no later than
April 10, 2009.
Mailing
Address
Shareholder proposals should be addressed to: IONA Technologies
PLC, The IONA Building, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland, Attn: Secretary.
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires our executive
officers, directors and any persons who own more than 10% of our
Ordinary Shares, collectively the Reporting Persons,
to file reports of ownership and changes in ownership with the
SEC. Reporting Persons are required by SEC regulations to
furnish IONA with copies of all Section 16(a) forms they
file. Reporting Persons were not required to file reports of
ownership and changes in ownership with the SEC during the year
ended December 31, 2007 because IONA, as a foreign private
issuer, was not subject to Section 16(a).
HOUSEHOLDING
All Members will receive one copy of IONAs Proxy Statement
and Annual Report on
Form 10-K
for the year ended December 31, 2007 at your address of
record. However, holders of ADRs who have the same last name and
share a mailing address may receive only one Proxy Statement and
Annual Report on
Form 10-K
from the broker or bank through which you own your ADRs. This
practice of sending only one copy of proxy materials is known as
householding. If you received a householding
communication, your broker will send one copy of IONAs
annual report and Proxy Statement to your address unless
contrary instructions were given by any shareholder at that
address. If you received more than one copy of the proxy
materials this year and you wish to reduce the number of reports
you receive in the future and save IONA the cost of printing and
mailing these reports, your broker will discontinue the mailing
of reports on the accounts you select if you mark the designated
box on your proxy card.
You may revoke your consent to householding at any time by
contacting Automatic Data Processing, Inc. (ADP),
either by calling toll free at
(800) 542-1061
or by writing to ADP, Householding Department, 51 Mercedes
Way, Edgewood, New York 11717. The revocation of your consent to
householding will be effective 30 days following its
receipt. In any event, if your household received a single set
of proxy materials for this year, but you would prefer to
receive your own copy, we will promptly send a copy to you,
please address your written request to either IONA Technologies
PLC, IONA Investor Relations, The IONA Building, Shelbourne
Road, Ballsbridge, Dublin 4, Ireland or IONA Technologies, Inc.,
IONA Investor Relations, 200 West Street, Waltham, MA 02451
or contact IONA Investor Relations in the U.S. at
781-902-8000
or in Ireland at
+353-1-637-2000.
43
Appendix A
IONA
TECHNOLOGIES PLC
ORDINARY SHARE FORM OF PROXY
THIS
PROXY FOR THE ANNUAL GENERAL MEETING IS SOLICITED BY THE BOARD
OF DIRECTORS
The undersigned Member of the Company, a public limited company
incorporated under the laws of Ireland, hereby acknowledges
receipt of the Notice of Annual General Meeting and Proxy
Statement, dated April 29, 2008, hereby appoint (See
Note B below):
(a) the Chairman of the
Meeting; or
(b)
of
as my/our proxy to vote all shares on my/our behalf which I/we
would be entitled to vote if then and there personally present,
on all matters set forth below and in
his/her
discretion upon such other matters as may properly come before
the Annual General Meeting of the Company to be held at The Four
Seasons Hotel, Ballsbridge, Dublin 4, Ireland, on Monday,
September 29, 2008 at 3:00 p.m. (local Irish time),
including for the avoidance of doubt, any Proposed Resolution to
adjourn all or any matters proposed for consideration at the
meeting and at any adjournment thereof.
NOTES:
|
|
|
|
A.
|
A Member must insert his, her or its full name and registered
address in type or block letters. In the case of joint accounts,
the names of all holders must be stated.
|
|
|
|
|
B.
|
If you desire to appoint a proxy other than the Chairman of the
Meeting, please insert his or her name and address and delete
the words the Chairman of the Meeting.
|
|
|
C.
|
The proxy form must:
|
|
|
|
|
(i)
|
in the case of an individual Member be signed by the Member or
his or her attorney; or
|
|
|
|
|
(ii)
|
in the case of a corporate Member be given either under its
common seal or signed on its behalf by an attorney or by a duly
authorized officer of the corporate Member.
|
|
|
|
|
D.
|
In the case of joint holders, the vote of the senior holder who
tenders a vote whether in person or by proxy shall be accepted
to the exclusion of the votes of the other joint holders and for
this purpose, seniority shall be determined by the order in
which the names stand in the register of members in respect of
the joint holding.
|
|
|
|
|
E.
|
To be valid, this proxy form and any power of attorney under
which it is signed must reach the Secretary of the Company at
the registered office (The IONA Building, Shelbourne Road,
Ballsbridge, Dublin 4, Ireland), or the Companys Registrar
at Computershare Investor Services (Ireland) Limited, Heron
House, Corrig Road, Sandyford Industrial Estate, Dublin 18,
Ireland, not less than 48 hours before the commencement of
the Meeting.
|
|
|
|
|
F.
|
A proxy need not be a shareholder of the Company but must attend
the Meeting in person to represent you.
|
|
|
|
|
G.
|
The return of a proxy form will not preclude any Member from
attending the Meeting or from speaking and voting in person
should he/she/it wish to do so.
|
Please indicate with an x in the space below how you
wish your votes to be cast in respect of each of the resolutions
detailed in the notice convening the meeting. A vote
withheld is not a vote in law and will not be
counted in the calculation of the proportion of the votes
for and against the Proposed Resolution.
THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS
INDICATED, WILL BE VOTED (OR WITHHELD) AS SAID PROXY OR PROXIES
DEEM APPROPRIATE IN RESPECT OF PROPOSED RESOLUTIONS 1 TO 5 BELOW
AND ON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE ANNUAL
GENERAL MEETING.
A-1
THE BOARD RECOMMENDS A VOTE FOR EACH OF THE
FOLLOWING PROPOSED RESOLUTIONS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROPOSED RESOLUTIONS
|
|
|
FOR
|
|
|
AGAINST
|
|
|
WITHHOLD
|
1.
|
|
Receive and Consider Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.(a)
|
|
Re-election of Mr. Kevin Melia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.(b)
|
|
Re-election of Dr. Seán Baker
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.(c)
|
|
Re-election of Mr. James Maikranz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.
|
|
Authority to fix Ernst & Youngs (Dublin) and
Ernst & Young LLPs (Boston) remuneration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.
|
|
Authority to Purchase Own Shares and Set Re-
Issue Price Range for Treasury Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature or other execution by the Member (See Note C
above):
|
|
|
|
Print Name and Address of Member:
|
|
A-2
Iona Technologies Adr (MM) (NASDAQ:IONA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Iona Technologies Adr (MM) (NASDAQ:IONA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024